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Chapter 1: Introduction 
Summary 
Bone development and regeneration involves a balance between breakdown 
and synthesis of bony elements in the skeleton. These two processes are 
carried out by osteoclasts and osteoblasts, and are influenced by endocrine 
factors, ageing and drug treatment. The disturbance in this harmonious balance 
leads to the diseases such as osteoporosis and osteoarthritis. Osteoclasts are of 
hematopoietic origin while osteoblasts are mesenchymal cells. The process of 
regeneration allows an organism to regain the function of an organ or structure 
damaged by injury or disease. Regeneration has interested scientists for 
centuries. In recent decades this field has gained great attention from 
biomedical researchers. The main purpose of this interest is to find a way 
where cells, tissues and structures lost due to mechanical injuries, disease or 
ageing can be restored through regenerative medicine. Lower animals like 
urodeles, amphibians and many invertebrates have retained their regenerative 
capabilities to a remarkable extent throughout evolution, whereas humans and 
most other vertebrate species seem to have lost much of regenerative abilities 
for lack of potential mechanism underlying this process. Among other 
organisms, many species of fish have also retained extensive regenerative 
capabilities even at adult stages. The zebrafish Danio rerio, a teleost, is known 
to retain regenerative capacity to a great extent in larval and adult stages, and 
can regenerate heart, notochord, lens, retina and many other organs in 
addition to scales and fins. Here, I review some key literature concerning bone 
and tissue regeneration in the vertebrates, with special emphasis on the 





Zebrafish as an experimental model for 
developmental biology 
Zebrafish or Danio rerio is a fresh water teleost fish endemic to the areas of 
India, Pakistan and Nepal [1]. The total body length at maturity can reach up to 
3-4 cm [2]. The presence of black and white stripes on the skin, gives an 
appearance which is comparable to the zebra hence named as zebrafish [3]. 
Adult fish has a streamlined laterally compressed body with one dorsal fin, one 
ventral fin, a notched caudal fin and two pectoral fins which help in swimming. 
The mouth protrudes outward and dorsally but is devoid of any teeth; however 
there is a row of pharyngeal teeth in the 5th pharyngeal arch to chew the food 
[4]. It has long been used as a pet, but its importance as an experimental animal 
was only realized after initial studies done by Creaser et al [5]. It has a life 
expectancy of 3-4 yrs. The young fish reach maturity and start to reproduce at 
about 3 months of age. Zebrafish is known for high fecundity, each female fish 
can lay around 200-300 eggs per mating, the eggs are fertilized externally. 
These eggs can be placed in Petri plates until they hatch and reach larval stage 
where they begin to feed, at around 5 days post fertilization [4].  
Zebrafish eggs are highly suitable for developmental research [6]. One of the 
marvels of nature is that the eggs are virtually transparent and have a very fast 
rate of development. The most exciting feature for developmental biologists is 
that all the morphogenetic movements can be easily observed under a 
dissecting microscope. In contrast to the other experimental animal models the 
fast rate of development leads to the formation of most of the organs by 38 h 
post fertilization [3]. The embryos develop inside a transparent external chorion 
from which they hatch at around 2 -3 dpf and immediately start swimming 
freely. The embryos at this stage carry all of their nutrients in the form of yolk 
cells enclosed in a round yolk sac therefore no food is needed for first 5 days. 
Young larvae at 5 dpf can then be supplied with baby fish food and raised in 
medium-sized containers with constantly flowing water (for further protocols, 
see [7]).  
The large number of eggs per batch makes it the most appropriate 
experimental animal for large scale screenings (for examples, see [8,9]) Short 




lines. External development of zebrafish embryos without parental care makes 
it most suitable for behavioural studies [10-13]. Another great advantage of 
using zebrafish as an experimental model for achieving genetic studies is that 
the sequence of zebrafish genome is available. In addition, the transparency of 
embryos and larvae is also ideal for whole mount staining procedures, thus 
making it possible to analyze in whole mount organism.  
The Developmental Biology of Zebrafish Bone 
Bone Metabolism 
Normal bone development and turnover is a fine balance between bone 
breakdown (catabolism) and bone formation (anabolism). The chief cells 
involved in these complementary processes in the vertebrates are as follows 
[14]: 
• Osteoblasts, which are derived from the mesenchymal stem cells, and 
which give rise to bone-depositing osteocytes; 
• Osteoclasts, derived from mononucleated precursor cells of the 
haematopoietic lineage, and which fuse to form multinucleated cells.  
In human beings, there is a very high rate of bone turnover during childhood, in 
which formation exceeds resorption. Formation and resorption are in 
approximate balance in young adulthood, but with ageing there is a net loss of 
bone [15]. 
Throughout life, bone Remodelling takes place in foci containing osteoblasts, 
osteoclasts and their precursors, and the processes are coupled and in the 
healthy person, are in equilibrium. Both of these cell types arise from distinct 
cell lineages and maturation processes. Osteoblasts arise from mesenchymal 
stem cells, while osteoclasts differentiate from hematopoietic 
monocyte/macrophage precursors [14]. If the balance between the activities of 
these two cell types is disturbed, this can lead to loss of bone density 
(osteoporosis) or to increased bone formation (osteopetrosis). Loss of bone is 




Studies on osteoclasts in mammals 
Osteoclastogenesis is dependent on cytokines, of which two main are RANK-L 
(receptor activator of nuclear factor-κB ligand) also known as TRANCE (TNF-
related activation-inducing cytokine) and MCSF (macrophage colony stimulating 
factor [18-20]. For a summary of genes involved in bone Remodelling, see Table 
1. MCSF (macrophage colony stimulating factor) is considered critical for the 
proliferation of osteoclast progenitors, whereas RANK L controls the 
differentiation process directly by activating RANK. It has been established that 
RANK works in close cooperation with certain other receptors like OSCAR 
(osteoclast-associated receptor) and TREM 2 (triggering receptor expressed on 
myeloid cells) [15]. Stimulation of RANK and of the immunoglobulin-like 
receptors cooperatively phosphorylates ITAM (Immunoreceptor tyrosin based 
activation motif).  
Authors of [21] studied the differentiation of osteoclast precursors into 
osteoclasts in mice.  MCS-F stimulated the proliferation of macrophage 
precursors and their expression of osteoclast markers (RANK and TRAP; 
tartarate resistant acid phosphatase) in vitro, a macrophage cell line behaved 
also in this way. During this process the cells changed from spindle-shaped to 
round (pre-osteoctyes) and finally to multinucleated. The macrophage marker 
CD14 was simultaneously down regulated. Also down regulated was OPN 
(osteopontin) which is characteristic of M-CSF dependent cells but this 
expression weakens after differentiation into pre-osteoclasts. Carbonic 
anhydrase 2 is expressed in the mature osteoclasts but not in the precursors, its 
expression is noticed in the cytoplasm and the inner surface of the ruffled 
border [22] 
Studies on osteoclasts in fish 
Matrix degradation by osteoclasts is a key process in both normal bone 
turnover and the bone disease osteoporosis [23]. Osteoclasts are classically 
described (at least in mammals) as multinucleated giant cells of the myeloid 
(monocyte-macrophage) lineage [15,24]. They display a characteristic ruffled 
border where proteases and hydrogen ions are secreted, allowing for bone 
resorption and formation of ‘resorption pits’ in the bone surface [25]. 




and also between different groups of teleosts [24]. In the skeleton of young 
zebrafish, for example, osteoclast activity is carried out by both mononucleated 
and multinucleated cells [26]. In fact, there is an ontogenetic progression from 
mono- towards multinucleated osteoclasts [26]. In juvenile zebrafish, bone 
resorbing cells in the developing lower jaw are at first mononucleated. In thin 
skeletal tissues such as the neural arch, mononucleated cells are predominant 
in adults [26]. In rainbow trout, scale resorption is predominantly carried out by 
mononucleated osteoclasts [27].  Although in mammals these mononucleated 
cells are often just regarded as osteoclast precursors, in fish mononucleated 
osteoclasts are active bone resorbing cells [28,29]. 
One family of osteoclast proteases are the matrix metalloproteinases (MMPs). 
They are involved in the breakdown of extracellular matrix by osteoclasts, but 
also by other cell types like fibroblasts [30]. MMPs are multi-domain enzymes 
that require zinc as cofactor for proteolytic activity. Extracellular matrix 
turnover occurs in a wide range of physiological processes, including embryonic 
development and morphogenesis, bone resorption and tissue regeneration. 
Moreover, MMP-mediated breakdown of the extracellular matrix has been 
implicated in disease processes including cartilage destruction in osteoarthritis 
[31]. The importance of MMPs in bone development is underlined by studies on 
mmp-2 and mmp-9 null mice, which suffer from bone abnormalities, 
osteoporosis and osteopetrosis respectively [32]. In view of their role in 
physiological and pathological processes, MMPs are important targets in 
pharmaceutical research and drug development.  
In bone turnover, secreted MMPs participate in the breakdown of collagen, 
which in turn allows osteoclast attachment [33]. Furthermore, MMP-9 is 
associated with osteoclast migration through the collagen matrix [34]. Matrix 
metalloproteinases may also break down residual collagen left by cathepsin K 
after the pH rises in the resorption pit [35]. MMP-2 and MMP-9 (gelatinase A 
and B, respectively) are particularly active against gelatins (denatured 
collagens) and intact collagen types I and IV. In the bone of dermal origin, 
matrix degradation is thought to rely more on MMPs and less on cathepsin K 
[36]. MMP-2 has also been described to play a crucial role in formation and 
maintainance of the osteocytic canalicular network whereas MMP-9 is active in 
early calvarial bone development and in orthodontic tooth movement [37]. 




inhibited by the MMP inhibitor GM6001 [38]. More recently, MMPs have also 
been implicated in angiogenesis and liberation of growth factors [39,40].  
TRAP and cathepsin K in situs in the newly-hatched medaka (stage 40-44 of [41] 
show a specific labelling of cells [42]. They found strong scattered expression in 
the pharyngeal region and teeth.  The labelled cells were both mononuclear 
and multinucleated with typical ruffled borders. Expression of mmp-9 gene has 
been studied in different embryonic and adult stages of zebrafish, it is 
expressed in the myeloid cells [43] 
Table 1 Genes expressed by osteoclasts or their precursors 











CD14 Macrophages (NOT 
osteoclasts).  
[21] 10934646 
CD43 pro-osteoclasts [21] 10934646 





RANK/OPGL/TRANCE Pre osteoclasts [46-49]  
Oscar Myeloid cells- 
Mature DC 
[50] 15155468 
























Pre osteoclasts [55] 17273786 




Bone turnover and Disease 
Parathyroid hormone and menopause 
Primary hypothyroidism and hyperthyroidism affects bone turnover. Decreased 
bone mass and high bone resorption occurs when there is an up-regulation in 
thyroid hormones and suppression in thyroid stimulating hormone. This effect 
was observed even in patients with subclinical hyperthyroidism [56]. 
 In women facing menopause, bone turnover is up-regulated with increased 
activity of osteoclasts and osteoblasts. The net effect of imbalance between 
bone deposition and resorption is bone loss [57,58] and in most of the cases 
the primary reason for this imbalance is loss of estrogen. Estrogen deficiency 
directly or indirectly increases the number of osteoclasts. In a study it is 
reported that an alternative mean by which TNF alpha modulate post-
menopausal osteoporosis may be FSH (follicle stimulating hormone) arising as a 
powerful inducer of osteoclastic bone resorption [59]. 
Effects of ageing on bone metabolism 
With increasing age the balance between bone deposition by osteoblast and 
bone resorption by osteoclasts is lost. In childhood there is more bone 
deposition and less bone resorption, after 20 yrs of age there is a balance 
between deposition and resorption but later to 25 yrs less deposition and more 




resorption, leading to greater incidence of osteoporotic conditions at old age. 
This weakening of calcified skeleton in elderly population is similar between 
males and females [58].  
Osteoporosis 
This group of disorders results in increased fracture risk because of reduced 
bone mass and poor bone quality [60]. A variety of medical conditions such as 
diseases or use of certain medications that adversely affect skeletal health 
leads to secondary osteoporosis. Studies suggest that 20 to 30 % of 
osteoporotic cases are secondary [61].  
There are three main causes of osteoporosis namely ageing, oestrogen 
deficiency and glucocorticoid use [62,63]. Osteoporosis can be treated by 
inhibiting resorption using estrogens or bisphosphonates (the latter inhibit 
osteoclast function) [64]. There is a continuing search for drugs that stimulate 
bone formation (anabolic agents) or better still, stimulate formation and 
suppress resorption at the same time.  One potential target is Cas-interacting 
zinc finger protein (CIZ), which inhibits bone formation without affecting 
resorption. Therefore inhibitors of this gene might be effective therapeutics 
[60].  
 Ciz -/- mice have increased bone mass. Calcitonin is also widely accepted as an 
Osteoclast inhibitor, studies in teleost and mammals suggest that calcitonin 
suppresses the activity of osteoclasts [51,52]. 
Glucocorticoid-induced osteoporosis (GIOP) is a major clinical problem given 
the widespread use of steroids [65]. It is the most common cause of secondary 
osteoporosis and the association between glucocorticoid use and increased 
fracture risk is well established. These agents even at low doses, can cause 
severe reduction in bone formation and can to a lesser extent increase bone 
resorption [61]. Multiple oral corticosteroid bursts over a period of years can 
produce a dosage-dependent reduction in bone mineral accretion and 
increased risk for osteopenia in children with asthma [66].  
Osteoporosis also occurs in ageing men but its progress is relatively slower, 
occurring due to prolonged continuous drop in free serum testosterone. 





This disease results in a loss of distinction between cortex and trabeculae of the 
bone. Resorption and skeletal Remodelling are dysfunctional resulting in 
abnormally shaped bone [68]. The unique feature of this disease is the 
accumulation of cartilaginous bars surrounded by bone throughout the marrow 
cavity. This results in a structurally compromised bone explaining the easily 
breakable bones of osteoporotic patients [69]. Most forms occur due to 
dysfunctional ion transporting proteins in the osteoclast which results in failure 
of acidification of the resorptive microenvironment [68]. 
Pyknodysostosis 
Mutation in cathepsin K gene in humans promotes osteoclast dysfunction 
resulting in a sclerotic bone disease distinct from osteopetrosis. The cathepsin K 
dysfunction disorder is described by diffuse skeletal sclerosis short stature and 
distinct cranio-facial abnormalities in addition to the dissolution of terminal 
phalanges of hands and feet. Pyknodisostotic patients also experience 
increased fracture risk [70,71]. 
Silica Nanoparticles for drug delivery 
In addition to studying the expression of markers, we also wanted to see 
whether we could perform functional studies for manipulating cell 
differentiation. For this purpose, we chose Mesoporous silica nanoparticles 
(MSNPs) as new drug delivery system (DDS) to deliver osteoclastogenic 
compounds such as MCSF and RANK-L in zebrafish embryos. These were 
already under development in our research consortium, and so this provided an 
interesting opportunity to incorporate them into this study. They have been 
used for cell culture studies [72], but testing their suitability in zebrafish 
provided us with an interesting possibility to develop an in vivo delivery system. 
MSNPs are a new DDS the toxicity of which in the zebrafish embryos needs to 
be studied carefully. The immunotoxicity of MSNPs is not known in zebrafish 
embryos previously. Therefore in order to use as DDS we needed to carefully 





Nanoparticles are being synthesized as a next generation of materials used for a 
variety of applications such as electronic devices, clothes, sunscreens and 
cosmetics [73].  There is variety of nanomaterials such as metal nanoparticles, 
nanoshells, Fullerenes, quantum dots, polymer nanoparticles, dendrimer, 
liposomes [74-84]. In future, nanomaterials may be applied for disease 
diagnosis and for drug delivery targeted at specific sites for example useful to 
treat cancer cells [85]. 
Nanomaterials in Cell culture 
Studies of uptake of hydrophobic silica nanoparticles on human breast cancer 
cells (MCF-7) and rat neural stem cells (NSCs; [72] elucidate the capacity to 
carry proteins unchanged into the cytosol. In vitro studies with HeLa cells has 
demonstrated the uptake efficiency and uptake mechanism of mesoporous 
silica nanoparticles (MSNs) can be manipulated by the surface functionalization 
of nanoparticles [86]. MSNs can be efficiently employed as carriers for 
intracellular drug delivery in cell cultures [87]. Previous studies have shown that 
non-phagocytic eukaryotic cells can endocytose latex beads up to 500 nm in 
size. Particles around 200 nm in size or smaller are taken up with highest 
efficiency, whereas very little uptake has been observed for particles larger 
than 1 µm [87]. 
Toxicity in vivo systems 
In zebrafish the toxicity assessment of gold and silver nanoparticles shows a 
higher toxicity of silver compared to gold [88]. The visual inspection of heat 
map to rank the high content data was ranked for toxicity of nanoparticles as 
QD1>ZnO.Pt>SiO2> Ag>AL2O3=Au [89]. It is also found that Fullerenes C60 cause 
oxidative stress in juvenile large mouth bass [90]. Silica nanowires were found 
to be more toxic as compared to silica nanoparticles in zebrafish embryos when 
administered in surrounding water [91]. In vivo biodistribution and toxicity 
depends on nanomaterial composition, size surface functionalization and route 
of exposure [92]. 
It has been found that toxicity of nanoparticles may vary with size, structure 
and composition of nanoparticles [93,94]. Mice have also been used for 




mice include the spleen, lymph node, and bone marrow [96]. All of these 
organs contain large concentrations of macrophages, involved in the uptake 
and metabolism of foreign molecules and particulates [96]. It has been 
observed that surface-modified nanostructures that are coated with the 
polymer polyethylene glycol (PEG) are capable of avoiding reticulo-endothelial 
system uptake [97]. In order to understand the fate and interaction of 
nanomaterials with the immune cells further studies are needed.  
Regeneration in zebrafish 
The adult zebrafish as some other teleost fishes possess an ability to regenerate 
some parts of the body such as heart, liver, fins and scales [2,98]. This ability 
makes it possible to study various processes involved in regeneration to be 
useful for regenerative medicine. The purpose is to help understand the 
mechanisms and establish methods to increase the regenerative capability in 
humans where it is only found in the form of wound healing.   
Osteoclasts on regenerating zebrafish scales 
Zebrafish scales have the ability to regenerate quickly when removed from the 
skin, or damaged by abrasion [99]. Scales can be studied to get a better 
understanding of the underlying mechanisms of skeletal development, such as 
matrix formation and degradation, cell differentiation and mineralization 
[54,99-101].  
Elasmoid scales are a component of the dermal skeleton and are composed of a 
collagen matrix mineralized with hydroxyapatite crystals on the exterior 
(episquamal) side [102]. Concentric ridges (circuli) and grooves (radii) radiate 
from the central focus to the edges of the scale giving it the specific form for 
zebrafish [103]. The scale matrix is synthesized and shaped during ontogeny 
and regeneration by the scleroblasts [104]. Scleroblasts are subdivided in 
osteoblasts and osteoclasts, based on their scale forming and resorbing 
properties, respectively in more recent literature [27]. 
The external layer is synthesized first, followed by the elasmodine layer which 
has a similar arrangement to that of mammalian lamellar bone [105,106]. New 
scale begins to be deposited immediately after the removal of the old one 




develop the regenerated scale to the original thickness, although there are still 
some structural differences between the normal and regenerated scales.  
Both in mammals and in teleosts, staining of tartarate-resistant acid 
phosphatase (TRAcP) activity demonstrates bone surfaces that are being 
actively resorbed or have been resorbed [24]. Indeed, mononuclear and 
occasional multinuclear osteoclasts, positive for TRAcP but also the osteoclast 
marker cathepsin K, were found on the episquamal side of scales of different 
fish species [100,108]. Multinucleated osteoclasts resorbing the scale matrix 
have also been identified by means of electron microscopy in fish [27,107,109].  
Adult Zebrafish fin regeneration 
Studies have been done to ascertain the process of regeneration in the 
zebrafish in addition to the generally used regeneration models such as 
anurans. However, most of the studies are focused on the regeneration of adult 
tissues in this vertebrate model [2,13,110-118]. The regeneration in the 
zebrafish caudal fin occurs in two steps; wound healing and blastema 
formation. Blastema is a tissue critical for appendage regeneration; it consists 
of proliferative stem cells which lead to the reconstruction of the lost tissue 
[119,120]. To achieve proper shape, size and structure of a regenerating tissue 
the blastema is regulated by surrounding influences in teleost species. In adult-
amputated zebrafish fins, the blastema develops at the site of each fin ray in 
turn driving regenerative events [115]. There is some compartmentalization of 
proliferating and non-proliferating regions in the adult zebrafish regenerating 
fin tissue. Mesenchymal compartmentalization is found to be critical for 
regeneration with a role of epidermal influence on the position and size 
[111,114]. There are eight different cell groups in the regenerating tail of adult 
zebrafish of which four cell types in the wound epidermis, three cell types in 
blastema and one is mmp9 expressing cell type [117]. 
Caudal fin regeneration in larval zebrafish 
It has been previously reported that the molecular mechanisms involving 
mesenchymal and epithelial cells in the tissue repair are the same in larval and 
adult fin primordia [121]. Larval fin repair occurs through the formation of 




proliferative cells present. Cell proliferation leads from the distal to proximal 
region in embryos as well as adults. It is suggested that neutrophils and 
macrophages are not deemed essential for regeneration [110]. According to 
[121] the cells in the regenerates are epidermal or mesodermal.  
The normal zebrafish embryonic fin fold extends posteriorly surrounding the 
dorsal and ventral sides of tail; this morphology is achieved by 28h post 
fertilisation [121] or between prim-6 and prim-16 of [122]. Till 6 dpf the fin is a 
simple structure composed of epithelial and mesenchymal cells with no 
cartilage and fin rays differentiated yet. Within three days of amputation the 
larvae retain the complete form and structure of the lost part of the tail [121]. 
Glucocorticoids and regeneration 
Glucocorticoids (GCs) are the steroid hormones secreted by the adrenal glands 
under stress conditions, and these hormones are also involved in the regulatory 
mechanisms of development, bone turnover, cellular apoptosis in general, 
metabolism, and circadian rhythm regulation [123]. Generally GCs are anti-
inflammatory and immuno-suppressive agents widely used clinically to treat 
autoimmune diseases, allergies, prenatal lung maturation, and transplant 
rejection [124-126].  
The secretion of glucocorticoids is a classic response to stress. It has been found 
by [127] after reviewing a large data of studies done on the role of 
glucocorticoids in various mechanisms studied. Depending on physiological 
endpoint in question glucocorticoid effect falls into different categories with 
mediating, suppressive or preparative actions. The regulation of actions of GCs 
is mediated by the glucocorticoid receptor (GR) which belongs to the nuclear 
receptor superfamily [128]. These genes are known to be highly conserved 
between species. Zebrafish is known to possess one GR gene. The main 
endogenous glucocorticoid in rodents is corticosterone while in humans and 
zebrafish it is cortisol [129] review).  
Dexamethasone is a synthetic analogue of the glucocorticoid class of steroid 
hormones 20 to 30 times more potent than hydrocortisone and 4 to 5 times 
more potent than Prednisolone [130-132]. This hormone is commonly used to 




reduce allergic response, to treat oncologic conditions and high altitude 
sickness due to neural oedema. Dexamethasone has been found to have some 
negative effect on wound healing by affecting collagenization, epithelization, 
and fibroblast content in mice even after single dose of 1 mg/kg [133]. 
Corticosteroids are known to reduce inflammation, which in turn affects cell 
migration, proliferation, and angiogenesis [134]. GCs mostly have a suppressive 
action on the immune and inflammatory response even at basal levels of 
glucocorticoid concentrations. There is also some evidence of permissive 
actions of glucocorticoids playing important roles. Therefore it can be assumed 
that the GCs present already permissively activate the immune response as the 
first response to a number of stressors, whereas stress induced GCs later 
suppress increased immune activation later. Corticosteroids are potent drugs 
that are extensively used for the treatment of inflammatory and autoimmune 
conditions. Same drugs however are also responsible for causing numerous side 
effects on many body systems [135]. 
Genes involved in regeneration of caudal fin 
RAR γ 
Retinoic acid is a signalling molecule for vertebrate pattern formation both in 
developing and regenerating tissue [136]. RARγ mRNA is the prominent RAR 
transcript found in normal regenerating tissue. RARγ is expressed in the distal 
ends of blastema of regenerating adult fin tissue [112]. 
Wnt3a 
Wnts are secreted glycoprotiens that play an important role in body patterning, 
cell proliferation, cell differentiation and tumour formation [137]. The function 
of this protein in body patterning occurs during early embryogenesis. Wnt3a is 
a ligand shown to activate β-catenin signalling. Wnt3a is a candidate for 
mediating the function of Wnt /β-catenin signalling during limb regeneration in 
newt [138]. Wnt 3a has also been shown to have expressed in the fin 
regenerates in adult zebrafish, found in the regenerating fin epidermis. β-
catenin expression thus is most likely important in maintaining fin epidermis 
and not necessary for regeneration [139]. Wnt signalling plays a role in the 
maintenance and renewal of stem cells which are cells that help repair the 





Expression of the transcription factor msxb reflects the growth rate of the 
blastema regulated by cues along proximodistal axis; msxb expression may also 
be required for the higher growth rate of proximal blastema cells [140]. 
Hoxd11 
Transcription factors like msxb and hoxd11 are regeneration-specific in the 
proximal blastema more than the distal. Mesenchymal cells of the blastema 
express the genes. It is known that their information on patterning resides in 
mesenchymal cells rather than the epidermis that covers them [140]. Msxb in 
conjunction with hoxd11 may be involved in converting positional information 
into various rates of cell proliferation such that distal blastema grows slower 
than proximal.  
Aims and Scope of this Thesis 
This thesis examines the cells, derived from the haematopoietic system, 
involved in Remodelling and regeneration of various tissues in zebrafish. We 
hypothesised that precursors for osteoclasts are found in early (5 dpf) embryos. 
If this hypothesis is proven correct, then it would have the practical benefit of 
indicating the potential of the zebrafish as an embryonic model for bone 
Remodelling. As there was no information on any such cells are present in 
zebrafish embryos that early in development, the first steps were to: 
1. Look for the expression of genes known to be expressed in osteoclasts.  
2. See whether we could activate expression of these genes with 
functional studies 
In chapter 2 we examined the hypotheses that early zebrafish embryos contain 
cells expressing osteoclast markers. To do this, we examined the expression 
patterns of a panel of markers known to be involved in bone Remodelling in 
other models. To further examine the hypothesis that these cells might be 
osteoclasts, we examined whether we could activate expression of cathepsin K 
using vitamin D3 and dexamethasone.  
In chapter 3 we activated TRAcP positive cells in zebrafish embryos by injecting 




further functional test of our hypothesis that cells expressing osteoclasts 
markers in zebrafish embryos might be osteoclasts. 
In chapter 4 we further characterised the cells expressing osteoclast markers by 
looking at the adult regenerating zebrafish scale model. This was in order to 
look for similarities between the well-characterised adult osteoclasts and the 
hypothesised osteoclasts in the embryo.  
In chapter 5 we examined whether glucocorticoid exposure in embryonic stages 
has long lasting effects on wound healing and regeneration. If so, this would 
support the hypothesis that cells involved in wound healing and regeneration 
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Chapter 2: Expression Patterns of Genes 
Associated with Bone and Tissue 
Remodelling in Early Zebrafish Embryos 
 
Abstract 
Genes involved in bone and tissue Remodelling in the vertebrates include 
matrix metalloproteinase-9 (mmp-9), receptor activator of necrosis factor κ-β 
(rank), cathepsin K and tartrate-resistant acid phosphatase (TRAcP). We 
examine whether these markers are expressed in cells of zebrafish of 1-5 days 
post fertilization. We also examine adult scales, which are known to contain 
mature osteoclasts, for comparison. In situ hybridisation, histochemistry and 
serial plastic and paraffin sectioning was used to analyse marker expression. 
We found that mmp-9 mRNA, TRAcP enzyme and cathepsin K GFP protein were 
expressed in haematopoietic tissues and in the cells scattered sparsely in the 
embryo. Cathepsin K and rank mRNA were both expressed in the branchial 
skeleton and developing pectoral fin. In these skeletal structures, histology 
showed that the expressing cells were located around the developing cartilage 
elements, in the parachondral tissue. In a transgenic zebrafish line with GFP 
coupled to cathepsin K promoter, cathepsin K expressing cells were found 
around pharyngeal skeletal elements.  We exposed prim-6 zebrafish embryos to 
a mixture of 1µM dexamethasone (DEX) and 1µM Vitamin D3. These 
compounds, which are known to trigger osteoclastogenensis in cell cultures, led 
to an increase in intensity of cathepsin K GFP expression around the skeletal 
elements as well as in haematopoietic tissue. Our findings suggest that cells 
expressing a range of osteoclast markers are present in early larvae. If this is 
confirmed, it could lead to establishing a zebrafish embryonic model for 
studying bone biology and disease. 




Bone and tissue Remodelling are normal processes in adult animals, and in 
developing embryos. The genes involved include enzymes that break down 
extracellular components, and cell signalling molecules involved in the 
activation of specialised cells involved in Remodelling [15]. There are two 
different kinds of cells associated with bone Remodelling, namely osteoclasts 
and osteoblasts which work in harmony in a normal healthy system [15]. Any 
irregularity or abnormality in the Remodelling process leads to certain 
pathological conditions such as osteoporosis [141].  
In some previous studies, mature osteoclasts have only been detected in 
developing zebrafish after 20 days post fertilization (dpf) [26]. These cells are 
initially mononucleated, although multinucleated osteoclasts are also present 
in the adult zebrafish [26]. A recent review [142]  has shown that the bone of 
zebrafish is osteocytic or cellular as opposed to the bone of most of the other 
advanced teleost fishes which are acellular or anosteocytic. Furthermore, those 
authors concluded that the osteocytes of zebrafish are mesenchymal analogues 
of the osteoblasts of mammals. The multinucleated osteoclasts of zebrafish 
display similar features to that of mammalian multinucleated osteoclasts, for 
example formation of Howship’s lacunae and staining positive for TRAcP 
(tartarate resistant acid phosphatase) enzyme [26]. The presence of two types 
of active osteoclasts (mono- and multi-nucleated) is not restricted to zebrafish 
but is common for many other teleost species such as Goldfish (Carassius 
auratus) and Carp (Cyprinus carpio).  
Resorption by large multinucleated cells is lacunar, whereas resporption by 
mononucleated cells is shallow and non-lacunar in many teleost species 
[143,144]. Therefore evidence from humans and other mammalians as well as 
teleosts suggests that a significant number of active osteoclasts are 
mononucleated [142,143]. In addition to a number of similarities with human 
and mammalian bone resorption there are differences in the regulation of 
mammalian to fish osteoclasts. The calcium homeostasis is based on the gills 
which are the target organs for calcitonin function  and the site of osteoclast 
origin in teleost fish is not the bone marrow [145], therefore it is considered 
that osteoclasts are formed in the head kidney and spleen [99,146].  
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Two molecules which are essential for initiating osteoclastogenesis are 
macrophage colony-stimulating factor (M-CSF) and receptor for activation of 
nuclear factor kappa B (NF-κB) RANK ligand (RANK-L). Both of these are 
expressed by stromal cells related to osteoblasts. RANK is itself expressed on 
osteoclast precursors [147]. Cathepsin K, MMP-9, carbonic anhydrase 2 and  
calcitonin receptor are expressed strongly in multinucleated osteoclasts and 
weakly in pre-osteoclasts [21].  
Another important enzyme in this context is tartrate resistant acid phosphatase 
(TRAcP) which is expressed in activated murine and teleost osteoclasts [26]. 
TRAcP is involved in hydrolysis of various substrates including components of 
bone matrix [148,149].  Increased levels of TRAcP activity may be detected in 
clinical disorders involving bone lysis, such as osteoporosis; and also in 
osteoarthritis and rheumatoid arthritis [150,151].Loss of function studies in 
mice reveal an important role for TRAcP in skeletogenesis [148]. As is the case 
with the archetypal multinucleated mammalian osteoclasts, the mono- and 
multinucleated osteoclasts of teleosts secrete TRAcP at the site of active bone 
resorption [28,144,152,153]. Thus TRAcP-staining can be specific for 
osteoclastic bone resorption (and also for sites where osteoclasts were 
previously active) [26,28,143]. Ballanti et al., [154] regard expression of this 
marker as one of the best ways to identify osteoclastic cells. 
RANK (also known as TNFRSF11A, TRANCE-R) is a member of TNF receptor 
super family. Together with its ligand, the TNF-family molecule RANK-L 
(TRANCE, or osteoclast differentiation factor, ODF) it is a key regulator of bone 
Remodelling, and is essential for the development and activation of osteoclasts 
[46]. RANK is expressed by osteoclast progenitors, mature osteoclasts, 
chondrocytes and mammary gland epithelial cells [47,48]. Mice with a genetic 
mutation of RANK have a complete block in osteoclast development, but after 
the administration of RANK the osteoclasts develop normally in those mice [49]. 
It is therefore established that the RANK-L expressed by osteoblasts and its 
receptor RANK expressed in osteoclast precursors are essential for 
osteoclastogenesis.  
Cathepsin K a cysteine protease expressed by osteoclasts and synovial 
fibroblasts is responsible for removing the organic matrix, mainly fibrilar type-1 
collagen, and solubilisation of the inorganic component (hydroxyapatite) [155]. 
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Cathepsin K is released as a pro-enzyme in the resorption pit having an acidic 
pH. Inhibition of cathepsin K by specific inhibitors results in the accumulation of 
undigested collagen fibrils in lysosomes within osteoclasts [155]. Cathepsin K 
expression is elevated in the synovium of rheumatoid arthritis patients [156]. 
Expression of cathepsin K is also localized within a range of cells at the site of 
cartilage erosion in rheumatoid arthritis [156,157].  
Members of the matrix metalloproteinase (MMP) family of genes are important 
for the Remodelling of the extracellular matrix (ECM) in a number of normal 
biological processes such as embryonic development, morphogenesis, 
reproduction, tissue resorption and Remodelling [158]. They also perform the 
same function, i.e. ECM Remodelling in some pathological processes, including 
cancer metastasis, and rheumatoid arthritis. Finally, MMPs are present in some 
snake venoms, where they may be involved in lysis of tissue in the prey 
[159,160]. 
It is important to understand the processes underlying the Remodelling 
process, since disease can arise if these are dysregulated. Therefore, as a step 
towards establishing a zebrafish model for bone diseases, we have 
characterized the expression of panel of osteoclast-associated markers in early 
stages of zebrafish development. Early stages are particularly desirable for 
establishing a model because they are free from the legal restrictions that apply 
to the use of adults, and are therefore more suited to high throughput assays. 
Experimental procedures 
Animals 
Danio rerio (zebrafish) was used as the animal model for expression profiling of 
selected genes and proteins. All experimental procedures were conducted in 
accordance with the Netherlands Experiments on Animals Act that serves as the 
implementation of” Guidelines on the protection of experimental animals" by 
the Council of Europe (1986), Directive 86/609/EC, and were performed only 
after a positive recommendation of the Animal Experiments Committee had 
been issued to the licensee. Spawning of Danio rerio took place at 26⁰C in 
aerated 5 litre tanks, in a 10h: 14h light: dark cycle. In each mating setup, two 
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females and one male fish were placed together. The eggs are usually laid after 
first light in the morning. They were collected within the first hour, sorted and 
distributed in Petri dishes, filled with egg water (14 gm ‘Instant Ocean®’ salt in 
100 ml of demi water). 
The eggs were cleaned and transferred to 9cm Petri dishes at a concentration 
of 60 eggs per dish. They were maintained at 28°C in atmospheric air in a 
climate cell, also with a 10h: 14h light: dark cycle. The Petri dishes were 
checked 4 h and 8  h  for dead and unfertilized eggs which were removed and 
discarded. After continued incubation in the Petri dishes at 28°C embryos were 
harvested each morning from day 1 to day 5 and fixed as follows. Eggs were 
immersed in 4% buffered paraformaldehyde (PFA) at 4°C overnight and then 
dehydrated in an ascending series of Methanol staring from 25% to 100% and 
finally stored at -20°C in 100% methanol. One and two day old embryos were 
dechorionated before fixation. 
Cloning of genes and synthesis of probe 
The NCBI genbank was searched for homologous sequences with the Blast X 
algorithm using zebrafish query. Only for cathepsin K (Goldfish, Carassius 
auratus, AB236968) and MMP-9 (Common carp, Cyprinus carpio, AB057407) did 
we find similar enough sequences for our goal and aligned them with their 
zebrafish counter parts. These alignments were used to design PCR primers 
based on conserved regions. The other primers were designed only using, 
mostly multiple, Zebrafish sequences. Primers are shown in Table 2 
Table 2 Nucleotide sequence of primers used for PCR 
Primer Nucleotide sequence 5`-3` Position 
 
Receptor activator of necrosis factor Kappa B  
 
RANK F1 TGGCGGAAGGAAAGATTCCTC 157 
RANK F2 TGTGGCTCTGACCGCAGTCC 243 
RANK R1 CGCAGTCCGGCTGACTCTG 1071 
RANK R2 CTGGGACTTTGCTGCAGTAGATGC 1060 






CTS K F1 GATGAGGCTTGGGAGAGCTGGAA 180 
CTS K F2 GACGATTTGGGAGAAGAACATGCTG 256 
CTS K R1 TTTCGGTTACGAGCCATCAGGAC 1013 





MMP 9 F1 TTCGTGACGTTTCCTGGAGATGTG 207 
MMP 9 F2 CACAGCTAGCGGATGAGTATCTGAAGC 253 
MMP 9 R1 TGGCTCTCCTTCTGAGTTTCCACC 1120 
MMP 9 R2 AATGGAAAATGGCATGGCTCTCC 1135 
 
The PCR parameters consisted of 5 min of denaturation, followed by 40 cycles 
of denaturation 95o C, 10 sec, annealing (10 sec), and extension 60 second 
ending with 10 min of extension at 72oC. The PCR products chosen for cloning 
had the following primer combinations: CTSK F1 & R2, MMP-9 F2 & R2 and 
RANK F2 & R2.The PCR products were cleaned using Wizard SV Gel and PCR 
Cleanup system (Promega: Leiden, the Netherlands). 
The ligation, cloning and transformation of plasmids in competent cells were 
done with the TOPOTA PCRII kit from Invitrogen (Breda, the Netherlands).  
White colonies of transformed cells were grown and checked by PCR. Samples 
were then sent for sequencing to Macrogen. All the sequence analysis showed 
a strong homology with the reference sequences. Linearization of template was 
done with restriction enzymes XbaI, XhoI, HindIII or BamHI, depending on the 
direction of the gene and potential restriction sites present in the product, and 
cleaned with Wizard SV Promega columns. T7 or SP6 RNA-polymerases (Roche) 
were used to synthesis the digoxigenin labelled RNA probes. The probes were 
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stored at -20oC. Also sense probes were prepared for all of the genes, and used 
as negative control in in situ hybridization (ISH). The genbank accession 
numbers of our PCR products are shown in Table 3. 
Table 3 Genbank accession numbers of the genes cloned and used for in situ 
hybridization in this study.  
Gene Genbank accession number 
MMP-9      HM239640 
CTS-K      HM239643 
CTS-K-1b   HM239644 
Rank      HM239645 
TRACP HM239646 
In Situ Hybridization (ISH) 
Fixed and dehydrated embryos (see above) were rehydrated from methanol by 
passing through descending concentration of methanol, namely 75%, 50%, and 
25% methanol. They were then washed twice in 1x phosphate buffered saline 
(PBS) with 0.2% Tween 20 (PBST) for 10 min each. In some cases, embryos of 2-
5 dpf were then bleached at room temperature with hydrogen peroxide until 
pigmentation had completely disappeared (10 to 12 min). One day old embryos 
were found to be too delicate for bleaching. Then they were washed twice in 
PBST for 5 min. Embryos were treated with Proteinase-K (10 µmg/ml) for 
incubation time that was varied according to the stage 1 dpf  10 min, 2 dpf 15 
min 3 dpf 20 min 4 and 5 dpf 40 min. Further processing of embryos was 
conducted, with minor modifications, according to Xu Q and D.G.Wilkinson 
[161]. 
Adult fish scales 
We fixated adult zebrafish skin with scales in 4% PFA at 4°C overnight and 
stored them in 100% methanol after dehydration. In situ hybridization was 
carried out as described above for embryos except that no bleaching was done 
and, proteinase-k treatment was done for 10 min. 
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Transgenic Cathepsin K larvae 
Cathepsin K transgenic GFP labelled zebrafish published recently [162] were 
kindly provided by Prof. Stefan Schulte-Merker . The eggs were obtained from 
one adult pair and were cleaned and sorted as described above (see ‘Animals’). 
At the prim-6 stage [122] the transgenic embryos were continuously exposed to 
a mixture of 1µM (DEX) (Sigma Aldrich Switzerland) and 1 µM vitamin D3  
(cholecalciferol; SERVA electrophoresis GmbH, Germany) for 4 days. Controls 
were treated in the same way except that DEX and vitamin D3 were not added. 
At 5 dpf, control and treated larvae were observed alive under confocal 
microscope. 
TRAcP enzyme staining 
Normal zebrafish embryos and adult scales were preserved in 100% methanol 
after rehydration through a graded series of methanol in PBST. TRAP enzyme kit 
(Sigma-Aldrich 387A-1KT, Chemie GmbH, Steinheim, Germany) was used for 
staining the embryos and scales according to the user instructions.  
Sectioning 
Sections were prepared from the whole mount ISH larvae. The larvae were 
dehydrated in graded ethanol, and embedded in wax using Histoclear as the 
intermediate reagent. Some sections were prepared with Technovit embedding 
after dehydration. 
Imaging 
Imaging of in situ embryos and sections was done using Nikon eclipse E800M 
equipped with DSF1 camera. For in vivo confocal imaging of the transgenic 
larvae, they were immobilized in 1% low melting-point agarose (SIGMA) after 
anesthesia (0.04% Tricaine). Imaging was done using a Zeiss observer LSM 500. 
Results 
In situ hybridization results for cathepsin K, rank and mmp-9 are shown in Figs. 
1-9.   




Hybridization patterns of cathepsin K are illustrated in Figs. 1 A-H and Figs. 2 A-
D. Embryos hybridized with sense probe showed no specific signal (Figs.1 B). 
With antisense probe (Figs. 1 A, C-H and Figs. 2 A-D), there was expression as 
follows. At 1 dpf, hybridization was seen in a longitudinal stripe of adaxial 
mesoderm cells along each side of the trunk (Figs. 1 A), the stripe being 
interrupted at intersomitic boundaries (Fig. 1 C). Histological sections (Fig. 2 A) 
showed that this staining was paranotochordal, extending laterally from the 
notochord towards the epidermis. Hybridization was also seen in the pectoral 
fin buds (Fig. 1 A).  
At 2 dpf, specific expression in whole mounts gave an appearance of skeletal 
elements in the head, (trabeculae cranii, branchial arches, and lower jaw) and 
in the cleithrum and pectoral fin buds (Fig. 1 D, E, and F). Histological sections 
showed that expression was perichondrial (Fig. 2 B). By 3 dpf the expression in 
the pectoral fin was reduced and by 4 dpf was faint (Figs. 1 G and H). At 5 dpf, 
expression in the branchial arches was indistinct in whole mounts but was still 
visible in histological sections (Fig. 2 B), where specific expression was again 
seen in what we assume to be the perichondrium of the branchial arches. 
However, as with the pectoral fin and the lower jaw, there was no staining in 
the cartilage itself. 
 To confirm the specificity of the probe we examined expression in adult scales. 
Here, the hybridization was specific and distinct. Large clusters of heavily-
stained cells were localized at the margins of the scales (Fig. 2 C). At higher 
magnifications these clusters could be seen to have many nuclei, the dark 
staining being localized to the cytoplasm (Fig. 2 D).  




 Fig 1 Cathepsin K gene expression by in situ hybridization in zebrafish embryos, scale 
bar=200µm unless otherwise mentioned. A Expression in rostral blood island, lateral 
sides of notochord and pectoral fin bud (arrow head), in 1 dpf embryo. B Sense control 
of A with no specific expression. C Detail of Fig 1 A showing expression in the lateral 
region adjacent to the notochord, (arrow heads) scale bar=100 µm. D 2 dpf embryo 
with expression in the Meckel’s cartilage (mc), ethmoid plate (ep), cleithrum (cl) 
palatoquadrate (pq) and pectoral fin bud (pf).  E Detail of Fig D scale bar=150 µm. F 
Detail of Fig E showing expression in the pectoral girdle and fin bud, scale bar=50 µm. G 
3 dpf zebrafish embryo showing expression in the pharyngeal arches, scale bar=200 µm. 
H 4 dpf larva with expression in the pharyngeal arches (arrow head).  




Fig 2 Cathepsin K gene expression by in situ hybridization in zebrafish larvae and scales. 
A.  Histological section through the posterior region of 1 dpf embryo expressing 
cathepsin K gene in the cells of adaxial mesoderm, (arrow heads) and pectoral fin bud 
(arrow) scale bar=100 µm. B Section through pharyngeal arches of 5 dpf larva showing 
expression around the cartilaginous elements within the arches, scale bar=50 µm. C 
Whole mount adult scale showing expression at the margin, scale bar=300 µm (arrow 
heads). D Putative multinucleated cell expressing cathepsin K in the marginal region of a 
scale, scale bar=20 µm. 
 
 
Fig 3 Rank gene expression in zebrafish embryos. A 1 dpf embryo expressing rank gene 
in the rostral blood island (arrow head) and ventral blood island (arrow) in addition to 
staining in the jaw region, scale bar=300 µm. B 3 dpf larva expressing rank in the 
pharyngeal arches, (arrow) scale bar=150 µm. C 4 dpf larva expressing rank in the 
pharyngeal arches (arrow), scale bar= 200 µm.  D Ventral view of 4 dpf larva with 
expression in the pharyngeal arches (arrow) and anterior end of the Meckel’s cartilage, 
scale bar= 200 µm.  




Hybridization patterns with rank antisense (Figs 3 A-D) and sense probes (Fig. 
not shown). Sense controls showed no hybridization. At 1 dpf, diffuse 
expression was observed in the head region, around the yolk sac and in the tail 
in the region of the ventral blood island (Fig. 3 A) where mmp-9 and cathepsin-k 
expression was also seen. At 2 dpf expression was observed in the cleithrum 
and pectoral fin bud. At 3 and 4 dpf rank expression was seen in the pectoral 
fins and the branchial arches (Fig. 3 B and C). At 5 dpf, expression was seen only 
in the branchial arches (Fig. 3 D). Histological sections through the branchial 
arches of 5d old larvae confirmed that expression was in the loose mesenchyme 
but not the cartilage elements (Fig. 4 A), the same being true of the pectoral fin 
(Fig. 4 B). In adult scales, staining was observed in the edges of the scales only 
(Fig. 4 C). 
mmp-9 
Hybridization patterns with mmp-9 antisense probes are illustrated in 
Fig. 5. At 1 dpf, hybridization was seen in the ventral blood island (also 
the site of rank and cathepsin-k expression. Expression of mmp-9 was 
also observed in the posterior extension of yolk sac. At 2 dpf, 
hybridization was seen in numerous, scattered cells in the head, 
pharyngeal region, on the yolk sac, near the ventral aorta and around the 
gut (Fig. 5 A and B). At 3 dpf, there was hybridization in individual cells 
scattered in the tissue including pharyngeal region and caudal 
hematopoietic tissue (Fig. 5 C). At 4 and 5 dpf a few cells expressing 
mmp-9 were found scattered on the rostral part of the body, but were 
less numerous than at earlier stages. 
 
  




Fig 4 Rank gene expression in zebrafish larvae and scales. A Histological section through 
pharyngeal arches showing rank expression in the arches (arrow), scale bar=50 µm. B 
Section through pectoral fin of 2 dpf embryo showing rank expression in the tissue 
around the cartilage (red) scale bar= 100 µm. C Whole mount adult scale with rank 
expressing cells on the margin, scale bar=100 µm 
 
          
Fig. 5 mmp-9 gene expression in zebrafish embryos; A 2 dpf embryo with numerous 
cells expressing mmp-9 gene in the head region (arrows), scale bar=150 µm. B 2 dpf 
embryo, ventral view, scale bar=100 µm. C 4 dpf larva with expression in the ventral 
blood vessel in the posterior region of the body, scale bar=30 µm. 
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Fig. 6 Whole mount in situ hybridization on adult scales with mmp-9 gene. A Expression 
in the radii of the scale, scale bar=100 µm. B mmp-9 expressing cell aggregates at the 
margins of a normal scale, scale bar=100 µm. C Multinucleated cells expressing mmp-9 
in the radii, scale bar=40 µm. D Scale hybridized with sense probe with no specific 
staining, scale bar=200 µm. 
 
We hybridized adult zebrafish scales as positive controls for mmp-9 expression. 
There was expression in the radii of the scales in mono- and multinucleated 
cells (Fig. 6 A). Specific and strong expression was observed in the margins of 
the scales similar to that of cathepsin K expression (Fig. 6 B). Higher 
magnification shows expression in the multinucleated cells within the radii (Fig. 
6 C). There was no specific expression in the margins or radii of the scales 
hybridized with the mmp-9 sense probe (Fig. 6 D). 
TRAcP enzyme staining  
Immunohistochemical staining with TRAcP enzyme was done on whole mount 
zebrafish larvae (Fig. 7A-D). In 1 dpf embryos, strong and specific enzyme 
staining was seen in cells in the ventral blood island. At 2 dpf expression in the 
cells in the heart and pericardium was visible (data not shown). Stained cells 
were also present in the ventral fin fold and along the caudal haematopoietic 
tissue or CHT. In 3 dpf embryos, cells scattered very sparsely over the body 
expressed TRAcP staining (Fig. 7 A and B). There were numerous cells stained 
with TRAcP enzyme in the tail region around the notochord. At 4 dpf there was 
staining at the rostral end of Meckel’s cartilage, in the pectoral fin and in the 
pericardial region. In the posterior region of the body, stained cells were 
present in the ventral vein. Similar to 4 dpf the expression in 5 dpf larvae was in 
the Meckels cartilage, pectoral fin (Fig. 7 C) and along the ventral blood vessels 
and near the somites (Fig. 7 D).   
TRAcP enzyme staining was also done on adult zebrafish scales as positive 
controls. Staining was observed at the lateral margins of the scales (Fig. 8 A) as 
well as very dense staining in some scales in the mid region along the grooves 
of normal scales (Fig. 8 B). However no TRAcP staining was seen in the radii of 
the scales in our specimens. With the same staining multinucleated cells within 
the mid region of the normal scale were seen (Fig. 8 C). 
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Fig. 7 TRAcP histochemical staining. A 3 dpf larva showing expression in the caudal 
hematopoietic tissue and blood cells (arrows) scale bar  50 µm. B Tail region of 4 dpf 
larva with expression in individual cells (arrows), scale bar 50 µm. C 5 dpf larva with 
expression at the pectoral fin (white arrow). Scale bar = 50 µm. D  5 dpf larva expressing 
TRAcP in a single cell on the left flank of caudal body region (arrow) inset showing D at 
low magnification. Scale bar = 550 µm 
 
 
Fig 8 TRAcP histochemical staining on zebrafish scales. A Scales on the skin of adult 
zebrafish expressing staining in the lateral margins (anterior to the top and dorsal to the 
right), scale bar= 200 µm.B Groove on a single scale with TRAcP staining, scale bar=20 
µm. C Putative multinucleated cell stained with TRAcP enzyme, scale bar=20 µm. 
Transgenic Cathepsin K Larvae 
GFP labeled cathepsin K transgenic zebrafish larvae showed expression in the 
pharyngeal region in the scattered cells (data not shown). After exposing the 
embryos continuously with DEX and vitamin D3 for 4 days, the expression was 
more strongly seen around the pharyngeal skeleton, in np (nasal placode), Mc 
(Meckels Cartilage), Bh (basihyal), cb (ceratobranchial), pf (pectoral fin) (Fig 9 A-
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D) . In the lateral view cathepsin K expression was clearly seen in the 
pharyngeal arches, ceratobranchials, pectoral girdle and pectoral fin. There was 
also expression around the otic vesicle (Fig 9 C and D). However, a weaker 
cathepsin K expression in the control transgenic larvae was observed (Fig 9 E 
and F). There was an interesting cathepsin K expression in the scattered cells 
within the ventral vein near the caudal body region of the treated larvae similar 
to TRAcP and mmp-9 (Fig 9 G and H). 
 
 
Fig 9 GFP labelled cathepsin-k transgenic zebrafish embryos. A Confocal image showing 
5 dpf larva with expression in pharyngeal skeleton (ventral view, anterior side 
upwards).  B DEX and vitamin D3 treated 5 dpf larva showing increased cathepsin-k 
transgenic expression in bh (basihyal), cb (ceratobranchials 2-5), Mc (Meckel’s 
cartilage), np (nasal placode), pf (pectoral fin). C DEX and vit D3 treated 5 dpf larva 
showing increased cathepsin-k expression, rectangle shows the area marked for 
fluorescence intensity assay. D Confocal image showing left lateral view (anterior 
directed to the left) of the 5 dpf control larva with expression around ov (otic vesicle), 
cb (ceratobranchial), pf (pectoral fin). E Lateral view of DEX and vitamin D3 treated 
larva showing the skeletal elements with strong GFP signal, pharyngeal arches (arrow 
head) and pectoral girdle (arrow). F Caudal region of a treated larva showing the ventral 
vein with scattered cells expressing GFP cathepsin-k (arrows) 
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Fig. 10 Measurement of relative fluorescence intensity showing significant increase in 
case of DEX + vitamin D3. Lines represent standard error mean. Each of the dots 
represents one control larva, and square represents each treated larva. 
Discussion  
We studied the expression in zebrafish embryos and larvae of a panel of genes 
that are associated with bone and tissue Remodelling. Differences in expression 
were seen between all of the genes and are summarized in Table 4. Similarities 
in expression were evident between cathepsin K and rank, on the one hand, 
and mmp-9 and TRAcP on the other. Cathepsin K transgenic expression in 
normal embryos was associated with both type of expression as observed in 
cathepsin K and rank as well as mmp-9 and TRAcP. 
Table 4 Summary of expression patterns of osteoclast markers in zebrafish 
development found in this study. 
Marker Expression 
cathepsin K pharyngeal skeleton and pectoral fin, and in 
CHT in case of (transgenic larvae) 
rank pharyngeal skeleton and pectoral fin 
mmp-9 scattered cells on whole body and CHT 
TRAcP scattered cells on whole body and CHT (at 5 dpf 
in Meckel’s cartilage) 
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Cathepsin K and rank 
In 1 dpf embryo hybridized with cathepsin K probe, adaxial staining was seen. 
We cannot say however, whether this expression represents either the slow 
muscle precursors or sclerotomal elements which are known to occur in this 
region [163]. Cathepsin K and rank expression was more restricted to the cells 
associated with pharyngeal skeleton and pectoral fin skeleton [164,165] in 
embryos older than 1 dpf. It is known that by 5 dpf osteogenesis occurs where 
cartilaginous skeleton transforms into calcified tissue [166]. Also this 
calcification or bone deposition occurs from outside in, that is the exterior part 
of bone is remodelled to deposit bone [167].  
We found expression of cathepsin K in the sections around pharyngeal arches, 
similar to the expression of osterix (SP7) in the perichondrium around the 
cartilage of a 4 dpf zebrafish embryos by (Kimmel et al 2010) [167] Therefore it 
is possible that this expression of cathepsin K mRNA may be due to osteoclasts. 
It is also important to note here that we found strong similarities in the 
expression of cathepsin K and rank genes in the larvae as well as in the adult 
scales. In the adult zebrafish scales the cathepsin K [168] and rank genes are 
both expressed in the marginal regions. This positive expression suggests that 
same genes are also expressed in the adult tissues which are known to carry 
osteoclasts [169]. However the scale-margin expression of cathepsin K, but not 
rank, was found in multinucleated cells. 
Cathepsin K reporter line showed a similar pattern of cathepsin K to the in situs, 
with cells scattered along the pharyngeal arches. Further work is being carried 
out at present to document the expression pattern of GFP cathepsin K in detail. 
When the embryos were exposed at prim-6 stage with 1µM of DEX and vitamin 
D3 for 4 days and then observed with in vivo confocal microscopy we found 
that there was much stronger expression of GFP cathepsin K gene along the 
skeletal elements. GFP expression was seen in all the skeletal elements which 
are known to have developed by this stage, compared to very weak expression 
in controls.  
Initial observations therefore suggest that there was activation in the GFP 
cathepsin K expression in DEX and vitamin D3 treated embryos. It was also 
found that GFP cathepsin K positive cells were present in the tail region along 
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the ventral blood vessel. This expression in the ventral blood vessel is similar to 
the expression of TRAcP positive cells as well as mmp-9 positive cells in normal 
untreated larvae. It can be therefore concluded that the mmp-9 mRNA, TRAcP 
enzyme and GFP cathepsin K protein expressing cells are not only found around 
the skeletal elements but are also found scattered in other parts of body 
specially blood vessels, which is logical considering hematopoietic origin of 
osteoclasts. 
mmp-9 and TRAcP 
In the present study, mmp-9 and TRAcP enzyme were both expressed in cells 
sparsely scattered all over the body. Unlike cathepsin K and rank, mmp-9 and 
TRAcP expression was neither specifically associated with the pharyngeal 
arches nor the pectoral fin. Expression of mmp-9 has been reported in cells 
scattered mostly on the head region and the posterio-lateral trunk, in embryos 
from 2-5 dpf [170,171]. The expression of rank in 1 dpf embryos in the ventral 
blood island and rostral blood island, and mmp-9 in the ventral blood island is 
also interesting as this is the site of haematopoiesis in the early embryonic 
stages of zebrafish development [172].  
TRAcP expression was observed in the skeletal structures such as Meckel’s 
cartilage only in 5 dpf larvae, but not in larvae younger than 5 dpf. Previous 
researchers have argued that TRAcP expression is a definitive marker for active 
osteoclasts [142]. It is also worth considering here that the enzyme 
histochemistry does not seem to penetrate deep into the calcified tissue in 
whole mounts as much as GFP cathepsin K expression. Further work is required 
to determine the nature of the cells expressing the markers characterized here.  
In adult scales the mmp-9, cathepsin K and TRAcP expression is similar except 
for additional expression in the radii of the scales in the case of mmp-9 
hybridization. One possibility is that mononucleated cells expressing mmp-9 in 
the radii of the scales are non-activated cells of the osteoclast lineage, whereas 
the multinucleated radial and marginal aggregates are mature osteoclasts. 
Nonetheless, the fact that marginal, multinucleated cells in the adult scales 
express mmp-9, cathepsin K and TRAcP is suggestive of an osteoclastic lineage 
as we found in other studies recently published for mmp-9 and TRAcP 
expression in adult zebrafish scales [42,168,169].  However here we for the first 
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time present expression of cathepsin K in the same cells and rank in 
mononucleated cells.  
Conclusions 
Our results show that genes associated with osteoclasts are expressed in early 
zebrafish development and in the multinucleated cells expressing mmp-9 and 
cathepsin K genes, and TRAcP enzyme, in adult scale osteoclasts. Our data with 
the transgenic cathepsin K larvae suggests an association with the larval 
pharyngeal skeleton; this is also comparable to our expression data of cathepsin 
K expression with in situ hybridisation. The TRAcP enzyme, mmp-9 mRNA and 
cathepsin K GFP transgenic line also show expression in the blood cells found in 
the ventral vein. The expression of cathepsin K in the reporter line was 
upregulated by DEX and Vitamin D3 treatment. Together these findings raise 
the possibility that osteoclast-like cells are present at early stages of zebrafish 
development. Further work is underway to determine the function of these 
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Chapter 3: Mesoporous silica 
nanoparticles as a compound delivery 
system in zebrafish embryos 
Abstract  
Silica nanoparticles can be efficiently employed as carriers for many drugs in 
vitro. Here, we use zebrafish embryos as a model organism to see whether 
mesoporous silica nanoparticles (MSNPs) can be used to deliver compounds in 
vivo. We injected 35-40 nl (10mg/ml) of custom-synthesized, fluorescently-
tagged 200 nm MSNPs into the left flank, behind the yolk sac extension, of 2 
day-old zebrafish embryos. We tracked the distribution and translocation of the 
MSNPs using confocal laser scanning microscopy. Some of the particles 
remained localized at the injection site, while others entered the bloodstream 
and were carried around the body. Embryo development and survival were not 
significantly affected by MSNP injection. Acridine orange staining revealed that 
MSNP injections did not induce cell death significantly. We also studied cellular 
immune responses by means of lysozyme-ds red transgenic embryos. MSNP-
injected embryos showed infiltration of the injection site with neutrophils, 
similar to controls injected with buffer only. In the same embryos, counter-
staining with L-plastin antibody for leukocytes/macrophages revealed the same 
amount of cellular infiltration of the injection site in embryos injected with 
MSNPs or with buffer only. Next, we used MSNPs to deliver two recombinant 
cytokines (MCSF and RANK-L) to zebrafish embryos. These proteins are known 
to activate cells involved in bone Remodelling, and this can be detected with 
the marker tartrate resistant acid phosphatase (TRAcP). Co-injection of these 
proteins loaded onto MSNPs produced a significant increase in the numbers of 
TRAcP positive cells after 2-3 days of injection. Our results suggest that MSNPs 
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can be used to deliver bioactive compounds into zebrafish larvae without 
producing higher mortality or gross evidence of teratogenicity.  
Introduction 
Recent years have witnessed an impressive growth of fundamental and applied 
research in the field of nanoscience and nanotechnology [73]. There is a wide 
variety of nanomaterials including metal nanoparticles, nanoshells, fullerenes, 
quantum dots, polymer nanoparticles, dendrimers and liposomes [74-84]. In 
the future, nanomaterials may be applied in disease diagnostics and for drug 
delivery targeted at specific sites, for example in the treatment of cancer [85]. 
The burgeoning field of the nanomaterials brings several advantages to the 
design of new drug delivery systems (DDSs), as they present very significant 
properties such as: a high surface area able to incorporate consistent amounts 
of drug; tunable pore size, shape and diameter; and a chemical surface which 
can be functionalized to achieve target release [173]. 
The design of a DDS is crucial for use in medical applications; therefore it has to 
present some characteristics such as manipulation of biological profiles, such as 
pharmacokinetics and pharmacodynamics, biodistribution and cellular uptake 
[86,174] . There are two important challenges in these fields: first, the DDS 
must protect the cargo from a harsh environment and immune response; 
second: it has to ensure the delivery to the desired site followed be release of 
active drug. To meet these challenges, the DDS has to present some 
prerequisites such as biocompatibility with the biological environment, efficient 
cellular uptake, and controllable rate of release to achieve an effective local 
concentration, or concentration gradient [175,176]. Mesoporous silica 
nanoparticles (MSNPs) can satisfy all these requirements [86].  
Previous studies have shown that non-phagocytic eukaryotic cells can 
endocytose latex beads up to 500 nm in size, and that the efficiency of uptake 
decreases with increasing particle size [87]. Particles around 200 nm in size or 
smaller are taken up with highest efficiency, whereas very little uptake is 
observed for particles larger than 1µm. Therefore MSNPs can be efficiently 
employed as carriers for intracellular drug delivery [87]. It was found in other 
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studies that the toxicity of nanoparticles may vary with size, structure and 
composition [93,94]. Acute toxicity occurs at nanoparticle concentrations in the 
order of milligrams per litre in the case of the medaka, Oryzias latipes, and the 
largemouth bass, Micropterus salmoides [90,177]. Silica nanoparticles were 
found to be non-toxic to other human and mouse embryonic cells at up to 15 
mg/l [178]. In addition silica nanoparticles were not found to have general or 
overt toxicity between 0.0025 and 200 mg/l [179].  
Mice have been used for studying nanoparticle biology [95]. Organs that can 
take up nanostructures in mice include the spleen, lymph nodes, and bone 
marrow. All of these are major organs of the immune system and contain large 
concentrations of phagocytic cells than can ingest the nanostructures. 
Nanostructures that are coated with polyethylene glycol (PEG), a polymer, have 
been shown to be more resistant to uptake by phagocytic cells [97].  
Zebrafish transgenic lines that express green or red fluorescent proteins (GFP or 
DsRED2) under a neutrophil-specific promoter, such as the myeloperoxidase 
(mpx) promoter [180,181] or the lysozyme C (lyz) promoter [182], provide 
useful in vivo models for real-time imaging and genetic analyses of 
inflammatory responses. Neutrophils and macrophages in zebrafish larvae can 
both be visualized by immunolabelling with anti-L-plastin antibody, while the 
expression of colony stimulating factor 1 receptor (csf1r) and the lack of mpx 
and lyz expression in macrophages can be used to distinguish them from 
neutrophils [180,183]. The elongated morphology of the cells expressing these 
markers further points to a macrophage identity [180]. Both the neutrophil and 
the macrophage populations are involved in the innate immune response 
towards infection and injury [180-183]. In order to understand the fate and 
interaction of nanomaterials with the immune cells, further studies are needed.  
Many features of the zebrafish (Danio rerio) model make it well-suited for 
studies of nanomedical applications. It has a short generation time (around 
three months), and a large clutch size (200-300 eggs), which allows high 
throughput assays at low cost [4]. Zebrafish embryogenesis is rapid, with most 
of the internal organs, including the heart, liver, intestine and kidney, 
developed by 96 h post fertilization (hpf) [3]. The optical transparency of 
zebrafish embryos, and their fertilization and development outside the mother, 
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enables an easy and thorough observation of drug effects on internal organs in 
vivo.  
The zebrafish is also a very attractive model to study the mechanisms 
underlying bone formation [184,185] because the key regulators of bone 
formation are highly conserved between mammals and teleosts, and the 
corresponding orthologs share significant sequence similarities, and an overlap 
in expression patterns, when compared to mammals [164,186,187]. Molecules 
essential to promote osteoclastogenesis [188] include: (i) Macrophage colony-
stimulating factor (M-CSF); (ii) receptor for activation of tumour necrosis factor 
kappa B (TNSF-κB or RANK); and (iii) RANK ligand (RANKL, OPGL or TRANCE).  
 The aims of this study are: first, to test the toxicity of MSNPs on zebrafish 
embryos; second: to test the effect of MSNPs on immune cells; and third: to see 
whether MSNPs can be used to deliver bioactive compounds into zebrafish 
larvae. For this latter objective, we chose M-CSF and RANK-L because they have 
a clearly defined biological readout, in the activation of osteoclasts [189]. 
Materials and Methods 
Mesoporous Silica Nanoparticle synthesis 
The mesoporous silica nanoparticles (MSNPs) were synthesized via sol-gel 
chemistry using cetyltrimethylammonium bromide (CTAB) and mesitylene as 
templates. The surfactant, CTAB, is used as template for the mesoporous 
structure; while mesitylene is used as pore-expanding agent to increase the 
pore size. The synthetic procedures were done according to Lin and co-workers 
[174]. The silica nanoparticles were functionalized with 2-[Methoxy 
(polyethyleneoxy) propyl] trimethoxysilane in order to create a PEGylate 
surface (Supporting Information 1.1). For laser confocal microscopy, a different 
batch of MSNPs were synthesized with the fluorescent label fluorescein 
isothiocyanate (FITC), the synthesis being done according to Zink et al [175] 
(Supporting Information). Fourier transform infrared spectroscopy (FT-IR) 
measurement: effective removal of CTAB was confirmed using a FT-IR Biorad 
Excalibur Series FTS 4000 (RT) and MSNPs were prepared in a KBr tablet.  
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Scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM) 
MSNPs were suspended and sonicated in methanol in order to avoid 
aggregation. 10 μl of suspension was deposited on an aluminium stub and 
coated with pure carbon with a sputter carbon coater. TEM (transmission 
electron microscope) was performed with a JEOL 1010 instrument at 60 kV. The 
sample was prepared as stated above and was deposited on a carbon-coated 
copper grid, and then air dried for 3 h.  
X-Ray Diffraction (XRD) 
The XRD was measured with a general powder difractometer with Cu radiation 
at 40 kV and 30 mA.  
Release of FITC-BSA from MSNPs 
Release of FITC-bovine serum albumin (FITC-BSA) from MSNPs was measured in 
1M phosphate buffered saline (PBS) at pH 7.24, by preparing a suspension of 1 
mg/ml of loaded MSNPs. MSNPs were washed twice in PBS to remove excess 
FITC-BSA. The release was determined by taking aliquots at different times. The 
aliquots were centrifuged and the UV-VIS absorbance of the FITC-BSA was 
measured to give quantitative information about the release (Fig. 1 E).  
Zebrafish embryos 
Maintenance of zebrafish (Danio rerio) adults took place at 26⁰C in aerated 5 
litre tanks, in a 10 h: 14 h light: dark cycle. In each mating setup two females 
and one male fish were present. The eggs were collected within the first hour, 
cleaned, sorted and transferred to Petri dishes filled with egg water (14 gm 
‘Instant Ocean®’ salt in 100 ml of demi water). Embryos were anesthetized with 
0.04% MS-222 (tricaine methanesulfonate) at 2 days post fertilization ( dpf) for 
microinjections.  
Mesoporous Silica Nanoparticle Injections 
The embryos were divided into two groups: treatment (injected with MSNPs in 
phosphate buffered saline) and control (injected with PBS only). The embryos 
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(2  dpf) were anesthetized and transferred to custom-made agarose gel moulds 
to hold them in place. The moulds were made with 5% agarose (molecular 
grade, Bioline Cat. BIO-41025) in PBS, heated to dissolve, and then cooled. 
Borosilicate glass capillaries (1 mm outer diameter x 0.78 mm inner diameter, 
Cat. GC100TF-10, Harvard Apparatus, Holliston, MA) were pulled using a needle 
puller. The resulting flexible, thin, closed tip was snapped off to open the 
capillary for injecting. Each tip was calibrated for the release of fluid in oil, and 
the diameter of the droplet in oil recorded. About 35-40nl of MSNP suspension 
was injected into the left flank of each embryo caudal to the yolk sac extension 
with an air pulse provided by a Parker Picospritzer 3 (Parker Hannifin, 
Pneutronics Division, NJ) at a pressure of 30 psi and time 10 µsec. The pulse 
was delivered immediately after the needle had been pushed through the 
epidermis.  
Human recombinant macrophage colony stimulating factor (MCSF) 40 ng/ml 
and Receptor for necrosis factor ligand (RANK-L) 400ng/ml in combination were 
loaded into MSNPs by soaking overnight and then centrifuged the MSNPs and 
protein suspension. The supernatant was removed and the MSNPs were 
resuspended in 1 x PBS. Resulting MSNP suspension in PBS was injected into 2 
days old embryos, and the embryos were fixated at 1, 2, 3, 4 and 5 days post 
injection for TRAcP enzyme staining. There was no difference between the 
results from PEGylated and non Pegylated nanoparticles. Therefore we used 
PEGylated MSNPs for our studies, to avoid immune response. After injection, 
the embryos were washed twice with fresh egg water and transferred into Petri 
dishes (30 embryos per dish) and maintained at 28°C until analysis.  
Embryo imaging and analysis 
Imaging (including time-lapse recording) was done with confocal microscopy 
(Zeiss observer LSM 500 inverted microscope), immediately after injection, and 
24 h post injection, to assess the uptake and distribution of the fluorescent 
MSNPs in the body of the living embryo. We recorded mortality, malformations 
and cell death as described in Supplementary information ‘Analysis of zebrafish 
embryos’. 
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Transgenic lysC::DsRED2 embryos for Neutrophils 
The transgenic lysC::DsRED2 embryos used in this study have been described 
previously [182]. The neutrophil-specificity of this line is supported by other 
studies [190]. Two groups, each consisting of 35 eggs, were injected with or 
without MSNPs. Embryos were imaged within 2-5 h post injection, at 24 h, 2 d 
and 3 d post-injection with confocal microscopy.  
L-plastin immunostaining 
For L-plastin immunostaining, we used the procedure adapted after Cui C, 
[191]. Incubation was done overnight at 4°C with rabbit anti-L-plastin (Mathias 
et al., 2007) in blocking buffer (1:500 dilution). Embryos were incubated for 2 h 
at room temperature in Alexa Fluor 405 Goat-anti-Rabbit antibody (Invitrogen, 
1:200). They were stored at 4°C and imaged using confocal microscopy. 
TRAcP staining 
Tartrate resistant acid phosphatase (TRAcP) staining was done with TRAP kit 
387A-1KT according to the manufacturer’s instructions (Sigma Aldrich Chemie 
GmbH, Steinheim, Germany). 
Quantitative analysis  
For lysC::DsRED2 transgenic embryos and L-plastin immunostaining the 
quantitative analysis was done by counting the total number of cells present in 
the area around the injection site (10 embryos/ group) from flattened z stacks 
of confocal images. The total number of TRAcP positive cells was counted 
manually under a compound microscope from the whole body on both sides 
(10 embryos/ group). Statistical analysis was done with one way Anova using 
Bonferroni post hoc test. 




Characterisation of MSNPs  
We synthesized mesoporous silica nanoparticles via a sol-gel technique with a 
pore-expanding agent (mesitylene) to a CTAB-templated emulsion system. The 
template was removed with a methanol acidic wash because CTAB has been 
demonstrated as a very toxic compound for cells [192] due to its capability to 
damage biological membranes and cause the release of intracellular enzymes. 
The effective removal of CTAB was checked via FT-IR (Fig. 1 A and B). The 
nanoparticle surface was modified with a PEGylated methoxysilane in order to 
reduce cluster formations in physiological fluids. The nanomaterials thus 
synthesised present an inner structure comparable to the MCM-41, as 
previously described [173,193] with a honeycomb arrangement of the channels, 
as shown by the electron micrographs (Fig. 1 C and D).  
The particle size of MSNPs was measured with dynamic light scattering (DLS) in 
PBS solution (pH 7.2) before and after the PEGylation step. The hydrodynamic 
diameter of the particles, before the surface functionalisation is 985 nm (PDI 
±0.21) indicating an elevated tendency toward aggregation. Nevertheless, after 
surface modification the diameter measures 255 nm (PDI ±0.198) showing 
capability of particles to avoid clustering. A sharp peak was detected at, 2.8 
theta, showing the presence of a mesoporous structure with a pore size of ca. 8 
nm. We used bovine serum albumin (BSA) to study the properties of release 
and loading capacity of MSNPs. BSA was modified with fluorescein 
isothiocyanate (FITC) and then used to measure the release profiles of MSNPs. 
Loading capacity of MSNP-BSA in the supernatant was 65 μg/ml of loaded 
compound. The release curve shows the concentration of released BSA via UV-
VIS in the supernatant (Fig. 1 E). It shows a delay of ca. 1 hour, due mainly to 
two factors: (i) the steric hindrance of the BSA; and (ii) some ionic interaction 
between the silica scaffold of the nanoparticles and the positive charges of the 
amino acids of the chain. Variation of the ζ-potential of the MSNPs and protein 
loaded MSNPS was measured as a function of pH Fig. 1 F. 
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Distribution of nanoparticles after injection into embryos  
MSNPs conjugated with FITC-dextran were injected into the left flank of 
zebrafish embryos at 2 dpf, caudal to the yolk sac extension (Fig. 2 A). We found 
that some nanoparticles were seen circulating in the bloodstream (Fig. 2 A). 
while others were visible in the tissue at the site of injection, and remained 
there for the duration of experiment i.e. up to 5  dpf (Fig. 2 B). The earliest time 
examined was with CLSM was 10 minutes post injection, at which time the 
particles were already in the circulation. 
Toxicity Testing 
To see whether nanoparticles had an adverse effect on the development of the 
embryo we first recorded the cumulative mortality at 5 dpf (Fig. 3 A). 
Percentage mortality, pericardial oedema and morphological abnormalities are 
shown in Fig. 3A. Mean mortality in the MSNP-injected group was 5.8% and 
4.1% in the control group (PBS only; Fig. 3 A). In the MSNP-injected group, 
4.68% of embryos had pericardial oedema and skeletal abnormalities compared 
with 1.5% of controls. The skeletal abnormalities were of Meckel’s cartilage, the 
pharyngeal arches and the ethmoid plate, as revealed by Alcian blue staining 
(Figs. 3 B, C). Cell death, as indicated by acridine orange staining (Fig. 3 E), was 
quantified for the whole embryo at 24 h post injection, and was similar in 
MSNP-injected and control groups (Fig. 3 D). Statistical analysis showed that 
there was no significant difference between the MSNP-injected and control 
(PBS-injected) groups in terms of cell death, mortality or malformations. 
 
 





Fig. 1 Characterization of silica nanoparticles. A FT-IR of MSNPs before removal of CTAB 
template, double peak of quaternarium ammonium present at 2750 cm
-1
. B FT-IR of 
MSNPs after the removal of CTAB template; the double peak at 2750 cm
-1
 is removed 
with acidic methanol washing. (C) SEM image of MSNPs showing the homogeneous 
Wavelength (cm-¹) Wavelength (cm-¹) 
Time in hours 
pH 
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shape and diameter. D TEM image of MSNP showing homogeneous displacement of 
parallel channels. E Release of FITC-BSA from MSNPs, a delay of ca. 1.5 h is observed 
due to the interaction of the BSA with the silica scaffold of the nanoparticle, (y axis 
shows % of release). F Variation of the ζ-potential of the MSNPs (dots) and protein 
loaded MSNPS (squares) as a function of pH, (Y axis ζ-potential).  
  
Immune cell response to injection 
We examined the neutrophil response to the injection of MSNPs or PBS 
(control) in 2 dpf lyz::DsRED2 embryos from 2 h until 3 days after injection. At 2 
h post injection, the site of injection was already infiltrated by neutrophils (Fig. 
4 A, B). Neutrophils were still in the vicinity of the injection site at 24 h and 2 
days post injection (Figs. 4 C, D and E), but very few neutrophils remained at the 
















Fig. 2 Fluorescent MSNP injected zebrafish embryos. A MSNPs (green) distributed 
anteriorly and caudally from site of injection (boxed area); the black cells are pigment 
cells (melanocytes); scale bar, 100 µm. B MSNPs aggregated at the site of injection; 
scale bar 20 µm. 
 
Fig. 3 Toxicity of MSNPs in zebrafish larvae.  A Graph showing percentage of 1) 
mortality in larvae injected nanoparticles, 2) larvae affected by pericardial edema 3) 
normal morphology. The differences between buffer-injected (Control) and MSNP-
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injected (MSNP) embryos are not statistically significant. Bars indicate standard error of 
mean. B Embryo injected at 2 dpf with MSNPs and fixed and stained at 5 dpf with Alcian 
blue; it has a combination of abnormalities as follows: pericardial oedema, a malformed 
Meckel’s cartilage (Mc), anterior brachial cartilage (white arrow), posterior branchial 
cartilage (black arrow), and auditory capsule (aud). Scale bar, 200 µm. C Embryo 
injected at 2 dpf with buffer only, then fixed at 5 dpf and stained with Alcian blue. This 
embryo shows a normal pharyngeal skeleton. Scale bar, 200 µm. Although we selected 
this malformed embryo from the MSNP group, and the normal from the controls, there 
was no significant difference in the incidence of malformed embryos between buffer-
injected and MSNP-injected groups. D Quantification of Acridine orange stained cells in 
control (buffer-injected) and MSNP groups. There was no significant difference after 24 
h of injection between the two groups (10 embryos per group). E Acridine orange 
stained embryo with dead cells (green) in the eye, heart (h) and nasal placode (np). 
Other symbols: ov, otic vesicle. Scale bar, 100 µm. 
 
Large aggregations of neutrophils were seen at the site of injection regardless 
of whether MSNPs or buffer alone was injected (Fig. 4 A, B). There was no 
difference between MSNP-injected and PBS-injected embryos in terms of 
neutrophil infiltration in the larvae 2 days after injection (See supplementary 
Fig. 1). Additionally, we performed L-plastin immunostaining to image and 
quantify the accumulation of leukocytes. Like lyz-DsRED2 cells, L-plastin positive 
cells accumulated around the injection sites in both MSNP injected and control 
larvae (Fig. 4 G, H). Quantitative analysis revealed no significant difference 
between MSNP and control injections (Supplementary Fig 2). 
 
Supplementary Figure 1 Morphometric analysis of immune cells in lysC::DsRED2  
transgenic embryos, (A) Number of neutrophils 2 days post injection of PBS (veh) and 
MSNPs. (B) L-plastin positive leucocytes 2 days post injection of PBS (veh) and 





Supplementary Figure 2(A) Number of neutrophils 2 and 3 days post injection with 
Proteins or [Prot-MSNP]. (B) Number of neutrophils 2 and 3 days post injection of [PBS] 
and [Protein]. (C) Number of neutrophils 2 and 3 days post injection of MSNPs with or 
without proteins. (D) Number of total leucocytes 2 or 3 days post injection of [PBS] or 
[protein]. (E) Number of leucocytes 2 or 3 days post injection of [MSNP + PBS] or 
[Proteins+MSNP]. (F) Number of leucocytes 2 or 3 days post injection of protein or prot- 
MSNPs. 
Compound delivery 
In embryos injected with MSNPs loaded with a combination of 40 ng/ml of 
MCSF and 400 ng/ml of RANK-L, and then suspended in buffer, TRAcP positive 
cells were observed around the injection site (Fig. 5 A) and at many other 
locations distributed all over the body of the larvae (Fig. 5 A-F). We made a 
quantitative analysis of the total number of TRAcP positive cells throughout the 
body of the larvae 1-5 days after the injection of protein-loaded MSNPs. We 
found a significant increase in the number of TRAcP positive cells from 2 days 
post injection up to 4 days post injection compared to the controls. This 
increase in number seems to be transient as it returns to normal after 5 days. 
There was no significant difference in the number of TRAcP positive cells in the 
cytokine and cytokine-MSNP injected embryos 2 days and 3 days post injection 
(supplementary Fig. 2). 




Fig. 4 Confocal images showing injection site of lysC::DsRED2 transgenic zebrafish 
embryos/larvae. A Buffer-injected 2  dpf embryo 2 h post injection (overlay of tiles with 
z stacks). Note the neutrophils (red) at the injection site (arrow) and at more remote 
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sites. B An overlay of transmitted and confocal image of a different embryo showing 
MSNPs (green) Neutrophils (red) at the injection site 2 h post injection. C 
Representative overlay image of a different embryo injected at 2 dpf with MSNPs and 
analysed at 2 h post injection. This case shows a much smaller accumulation of MSNPs 
(green) neutrophils (red) at the injection site than B. D MSNP-injected embryo 24 h post 
injection. MSNPs (green), Neutrophils (red). E MSNP-injected embryo, 2 days post 
injection showing MSNPs (green), Neutrophils (red). F MSNP injected 3 days post 
injection (green), neutrophils (red), leucocytes (blue). G MSNPs (green) in 2 days post 
injection larva, Leucocytes (blue). H MSNP injected 2 dpf larva B-H are all to the same 
scale, bar= 50µm. 
 
Fig. 5 TRAcP enzyme staining in MSNP injected larvae, A TRAcP positive cells at the site 
of injection in 3 days post injection larva (arrows). B TRAcP positive cells in the head 
region under the eye (arrows) 3days post injection) C TRAcP positive cells in the heart 
region in 3 days post injection embryo (arrows). D TRAcP positive cells in caudal fin of a 
4 days post injection larva. E TRAcP positive cells in ventral side of head of a 4days post 
injection larva (arrows). F PBS injected larva 3 days post injection with no expression 
below the eye. Scale bar A, B, C, F, H = 50 µm, D 100 µm and E, 200 µm).  
 
There was also the rare presence of apparently multinucleated TRAcP positive 
cells in cytokine-loaded MSNP injected embryos (Fig. 6 A-D). Hematoxylin and 
TRAcP double-staining showed 3-5 nuclei in a cell (Fig. 6 B). One of these 
apparently multinucleated TRAcP positive cells in the somite area of a 3 days 
MSNPs as a Compound Delivery System 
56 
 
post injection larva in Fig. 6C was counter-stained with (DAPI) to visualise the 
nuclei (Fig. 6 D boxed area). Quantitative analysis of PEGylated cytokine-loaded 
MSNPs or buffer-loaded MSNPs in 2 days post injection and 3 days post 
injection groups showed that the number of TRAcP positive cells significantly 
increased compared to the buffer-loaded MSNP injected controls (Fig. 6 E).  
 
 
Fig. 6 (A) TRAcP expression in the somites of a 3 days post injection larva with 
apparently multinuclear cell. (B) TRAcP positive cells counter stained with Hematoxylin 
C TRAcP positive zebrafish larva showing apparently multinuclear cells (box) D TRAcP 
enzyme stained larva counter stained with DAPI showing 5-6 nuclei in the same area as 
C (box) Scale bar ABC=12.5 µm and D=12 µm E Quantitative analysis of TRAcP positive 
cells in 2 days or 3 days post injection, 10 larvae/group were studied for the number of 
TRAcP positive cells, analysis was done with One way analysis of variance * = p< to 
0.1,**= p < 0.01, *** p < 0.001. 
Discussion 
We have tested the toxicity, and the capacity for controlled drug delivery, of 
MSNPs injected into living zebrafish embryo. We find that there is no significant 
difference between the toxicity of MSNP injections, and buffer-only injections, 
as measured by several parameters (mortality, cell death, gross malformations). 
Injection of MSNPs led to an influx of immune cells at the site of injection that 
persisted for 2-3 days. However, the same type of influx was also seen in 
embryos injected with buffer alone, suggesting that it is not the MSNPs that are 
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responsible for the immune response, but some aspect of the injection 
procedure itself (tissue damage, for example). Indeed, it has previously been 
shown that trauma to zebrafish embryos (e.g. a fin clip or mechanical wounding 
with an injection needle) causes an influx of macrophages and neutrophils to 
the wound site [180-183].  
In all the studies reported here, we used PEGylated MSNPs because PEGylation 
is thought to avoid triggering an immune response against the particles 
[97,194]. With time-lapse imaging it is clear that some MSNPs remain at the site 
of injury, while others travel in the blood stream from the site of injection. The 
MSNPs localized at the site of injection were found to be there even after 3 
days.  
Even though the MSNPs are very small in size with an average diameter of 
200nm these particles have a very high surface area that can be used to carry 
drugs in our case cytokines. This small size helps in fast endocytosis by non-
phagocytic cells [96]. In our studies we found no significant toxic effects of 
injected MSNPs in the living embryos. This means that at low concentrations, 
MSNPs could be a very good delivery system in the whole organism. 
Nanomaterials such as fullerenes have been found to be excreted following oral 
administration or injections in mice [195] while others were shown to be taken 
up by immune cells. We observed very little co-expression of lyz: DsRED2-
labeled cells and MSNPs. This suggests that only a few of the particles are 
actively phagocytosed by neutrophils. With L-plastin immunolabeling, which 
stains leucocytes, more overlap with the fluorescent signal of the particles was 
observed, suggesting that part of the MSNPs may be phagocytosed by immune 
cells. 
Other studies have shown that, in the presence of artificially provided cytokines 
like MCSF and RANK-L, immune cells are activated into TRAcP+ osteoclasts 
[196]. We were not able to combine the double staining of fluorescent immune 
cells with the histochemical staining of TRAcP enzyme activity because the two 
protocols were not compatible. Using single-labeling, we found a significant 
increase of TRAcP positive cells in zebrafish larvae injected with MSNP-
cytokines, while there was no significant increase in the total number of 
immune cells in these embryos. Some of these TRAcP positive cells had multiple 
nuclei, as shown by DAPI staining. By 4-5 days post injection, TRAcP positive 
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cells appeared to become small and darkly-stained. One possible explanation 
for these observations is that the TRAcP positive cells were transiently induced 
by the injected cytokines in the early period (2-4 days) after injection, and 
returned to a normal level later on.  
Further work is required to clarify the differentiation status of the TRAcP 
positive cells. If it can be confirmed that young larvae have inducible osteoclast-
like cells, this would be interesting because zebrafish larvae have not previously 
been reported to have osteoclasts at the stages studied here. Furthermore, the 
presence of osteoclast-like cells in zebrafish larvae could lead to a disease 
model for bone disorders and for the study of effects, for example, of anti 
osteoporotic drugs. What is clear from our findings is that MSNPs can be used 
for drug or compound delivery in the zebrafish embryo with no excess of gross 
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Chapter 4: Matrix metalloproteinases in 
osteoclasts of ontogenetic and 
regenerating zebrafish scales 
Sharif F, de Vrieze E, Metz JR, Flik G, Richardson MK. 
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Abstract 
Matrix metalloproteinases (MMPs) are key enzymes in the turnover of 
extracellular matrix in health, disease, development and regeneration. We have 
studied zebrafish scale regeneration to ascertain the role of MMP-2 and MMP-9 
in these processes. Scales were plucked from the surface of anaesthetised adult 
male zebrafish, and the scales that regenerated in the scale pocket were 
recovered at various time points after plucking. Analyses consisted of (i) mmp-9 
in situ hybridisation; (ii) MMP-9 + TRAcP double-staining; (iii) qRT-PCR for mmp-
2 and mmp-9; (iv) zymography for gelatinolytic activity and (v) a hydroxyproline 
assay. We found that mmp-9 positive cells were confined to the episquamal 
side of the scales. Ontogenetic scales had irregular clusters of mono- and 
multinucleated mmp-9 expressing cells along their lateral margins and radii. 
During regeneration, mmp-9 positive cells were seen on the scale plate, but not 
along the lateral margins. Double staining for TRAcP and MMP-9 revealed the 
osteoclastic nature of these cells. During early scale regeneration, mmp-2 and 
mmp-9 transcripts increased in abundance in the scale, enzymatic MMP activity 
increased and collagen degradation was detected by means of hydroxyproline 
measurements. Near the end of regeneration, all of these parameters returned 
to the basal values seen in ontogenetic scales. These findings suggest that 
MMPs play an important role in Remodelling of the scale plate during 
regeneration, and that this function resides in mononucleated and 
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multinucleated osteoclasts which co-express TRAcP and mmp-9. Our findings 
suggest that the fish scale regeneration model may be a useful system in which 
to study the cells and mechanisms responsible for regeneration, development 
and skeletal Remodelling. 
Introduction  
The elasmoid scales of zebrafish (Danio rerio) can regenerate when removed 
from the skin, e.g. by abrasion or experiment. Like regenerating fin rays [197], 
scales can be studied to get a better understanding of the underlying 
mechanisms of skeletal development, such as matrix formation and 
degradation, cell differentiation and mineralisation.  
Elasmoid scales are a component of the dermal skeleton. They are composed of 
a collagen matrix that is mineralised on the external (episquamal) side with 
hydroxyapatite crystals [102].The episquamal side of the scale possesses 
concentric ridges (circuli) and grooves (radii) radiating from the central focus to 
the edges of the scale. Each radius is covered by a dermal space with cells and 
blood vessels embedded within a loose matrix [198]. Scleroblasts synthesise 
and shape the scale matrix during ontogeny and regeneration [104]. The 
external layer is synthesised first, followed by the elasmodine layer, composed 
of type I and V collagen fibres in a plywood-like arrangement [105]. The 
collagens of the elasmodine layer are similar in arrangement to mammalian 
lamellar bone [106] and mineralise slowly from the external layer [199]. When a 
zebrafish scale is plucked from its scale pocket, formation of a new scale is 
initiated immediately [107]. Already after two days, a new mineralised scale 
plate can be seen, but it takes up to four weeks for a new scale to grow to the 
size and thickness of the removed scale. As a consequence of this rapid 
reformation, the focus of early regenerating scales is less structured than that 
of ontogenetic scales. The typical grooves and radii appear late in scale 
regeneration, which is believed to be the result of basal plate Remodelling 
[101,200]. Note that in this context, the term ‘ontogenetic’ scale is used for the 
scales that developed during the early ontogeny of the fish, in contrast to the 
scales that regenerate after plucking.  
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The scale compartment constitutes a significant, readily accessible calcium 
source of fish as it can contain up to 20% of the total calcium in the body [201]. 
Fish withdraw calcium from their scales in periods of high calcium demand, 
rather than from their axial skeleton as mammals do [202-204]. However, 
mobilisation of scale calcium demands the same active and controlled 
mineralisation and demineralization. Scales are covered with a monolayer of 
cells, originally called scleroblasts, on both the mineralised and un-mineralised 
side [103]. More recent literature subdivides the scleroblasts in osteoblasts and 
osteoclasts, based on their scale forming and resorbing properties, respectively 
[27,205,206]. 
This is substantiated by the classical osteoblast marker alkaline phosphatase 
(ALP), found in hyposquamal scleroblasts [108]. Both in mammals and in 
teleosts, staining of tartrate-resistant acid phosphatase (TRAcP) activity 
demonstrates bone surfaces that are being actively resorbed or have been 
resorbed [146]. Indeed, mononuclear and occasional multinuclear osteoclasts, 
positive for TRAcP but also the osteoclast marker cathepsin K, were found on 
the episquamal side of scales of different fish species [100,108]. Multinucleated 
osteoclasts resorbing the scale matrix have also been identified by means of 
electron microscopy [27,109].  
Matrix degradation by osteoclasts is a key process in both normal bone 
turnover and the bone disease osteoporosis [23]. Osteoclasts are classically 
described (at least in mammals) as multinucleated giant cells of the myeloid 
(monoctye -macrophage) lineage [15,146]. They display a characteristic ruffled 
border where proteases and acid are secreted, allowing for bone resorption 
and formation of ‘resorption pits’ in the bone surface [25]. Osteoclast 
morphology varies between mammals and teleosts (bony fishes), and also 
between different groups of teleosts [146]. In the skeleton of young zebrafish 
for example, osteoclast activity is carried out by both mononucleated and 
multinucleated cells [26]. In fact, there is an ontogenetic progression from 
mono- towards multinucleated osteoclasts. In juvenile zebrafish, bone 
resorbing cells in the developing lower jaw are at first mononucleated. In thin 
skeletal tissues such as the neural arch, mononucleated cells are even 
predominant in adults [26]. In rainbow trout, scale resorption is predominantly 
carried out by mononucleated osteoclasts [27]. Although in mammals these 
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mononucleated cells are often just regarded as osteoclast precursors, in fish 
mononucleated osteoclasts are active bone resorbing cells [28,29]. 
One family of osteoclast proteases is the matrix metalloproteinases (MMPs). 
They are involved in the breakdown of extracellular matrix by osteoclasts, but 
also by other cell types like fibroblasts [30]. MMPs are multi-domain enzymes 
that require zinc as cofactor for proteolytic activity. Extracellular matrix 
turnover occurs in a wide range of physiological processes, including embryonic 
development and morphogenesis, bone resorption and tissue regeneration. 
Moreover, MMP-mediated breakdown of the extracellular matrix has been 
implicated in disease processes including cartilage destruction in osteoarthritis 
[31]. The importance of MMPs in bone development is underlined by studies on 
mmp2 and mmp9 null mice, which suffer from bone abnormalities, 
osteoporosis and osteopetrosis respectively [32]. In view of their role in 
physiological and pathological processes, MMPs are important targets in 
pharmaceutical research and drug development.  
In bone turnover, secreted MMPs participate in the breakdown of collagen, 
which in turn allows osteoclast attachment [35]. Furthermore, MMP-9 is 
associated with osteoclast migration through the collagen matrix [34]. Matrix 
metalloproteinases may also break down residual collagen left by cathepsin K 
after the pH rises in the resorption pit [35]. MMP-2 and MMP-9 (gelatinases A 
and B, respectively) are particularly active against gelatins (denatured 
collagens) and intact collagen types I and IV. In bone of dermal origin, matrix 
degradation is thought to rely more on MMPs and less on cathepsin K [36]. 
MMP-2 has also been described to play a crucial role in formation and 
maintenance of the osteocytic canalicular network, whereas MMP-9 is active in 
early calvarian bone development and in orthodontic tooth movement 
[37,207,208]. Regenerating fins of adult zebrafish express mmp-2 and 
regeneration can be inhibited by the MMP inhibitor GM6001 [38]. More 
recently, MMPs have also been implicated in angiogenesis and liberation of 
growth factors [39,40].  
Given the involvement of matrix metalloproteinases in bone Remodelling and 
fin regeneration, we predict the presence of MMP2 and MMP9 in scale cells. 
We furthermore predict an increased MMP activity in scale regeneration 
associated with scale matrix Remodelling. In the current study, we investigated 
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both expression of mmp genes and actual activity of MMP enzymes in the 
process of scale regeneration.  
Materials and methods 
Animals and scale collection 
Experimental procedures were approved by the ethical committee of the 
Radboud University. Wild type adult male zebrafish (Danio rerio) of 
approximately one year old were kept at 26 °C in 1.5 litre tanks under 12 h light: 
12 h dark cycle. Fish were fed twice a day with commercially available food 
(Tetramin, Tetra, Melle, Germany). Prior to scale harvesting, fish were 
anesthetised in 0.05% v/v 2-phenoxyethanol. Scales were carefully removed 
under a microscope from the left side of the body using watchmaker’s forceps. 
When necessary, fish were euthanised using an overdose of 2-phenoxyethanol 
(0.5% v/v) and then scales or skin were collected.  
To induce regeneration, approximately 50 scales were removed under 
anaesthesia from the left side of a fish. For analysis of gene expression and 
enzyme activity, ontogenetic (non-plucked) and regenerating scales were taken 
from the same fish (right and left sides of the body respectively). Fish were 
sacrificed for scale collection on days 4, 5, 6, 8, 11 and 14 (note that scales 
before 4 days of regeneration are too small to collect). At these time points, 40 
ontogenetic (right side) and 40 regenerating (left side) scales were collected for 
RNA isolation and zymography. Additional fish were used for in situ 
hybridisation and histological analysis on days 2, 4 and 8 of regeneration.  
In situ hybridisation 
Primers were designed based on the Danio rerio mmp-9 sequence (Table 1). 
The probe sequence was amplified by PCR, cloned in a TOPO vector (Invitrogen, 
Carlsbad, USA) which was used to transform competent cells. Samples of 
positive clones were then sent for sequencing to Macrogen Inc. (Seoul, South 
Korea). Linearization of template was done using enzyme Xho1. The PCR 
product was cleaned using Wizard SV Gel and PCR Cleanup system (Promega, 
Leiden, The Netherlands).  
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Skins samples were fixed overnight in 4% paraformaldehyde in phosphate-
buffered saline (PBS, pH 7.4, 4⁰C). Samples were subsequently dehydrated in a 
graded series of RNAse-free methanol solutions to 100%, and then stored at -
18⁰C. Prior to hybridisation, the skin samples were cut into 25mm2 pieces and 
impaled on Drosophila pins (Watkins & Doncaster, Cranbrook, UK) to prevent 
the tissue from curling during incubation. The skin pieces were rehydrated 
through a graded series of methanol and processed for in situ hybridisation 
using standard protocols adapted with minor changes from [161].  
Table 5 Sequences of the primers used to quantify relative gene expression 
levels and develop the in-situ hybridisation probe. 
Gene Accession nr. Sequence (5’ 3’) 
β-actin AF057040 Fw: CTTGCTCCTTCCACCATGAA 
Rv: CTGCTTGCTGATCCACATCT 
40s AY648802 Fw: GTGTGGTGACCAAGATGAAGATG 
Rv: ACGGTTGTACTTGCGGATGTAA 
mmp-2 NM_198067 Fw: GAGAACCAACAGACAAGCCATTG 
Rv: TCTGATCTGGGCTACAGCATCA 
mmp-9 NM_213123.1 Fw: CCAGTTGTGCCAACGAAACC 
Rv: GAAGGGACCACCTGAGTTGTG 
mmp-9 ISH NM_213123.1 Fw: CACAGCTAGCGGATGAGTATCTGAAGC 
(pos. 253) 
Rv: AATGGAAAATGGCATGGCTCTCC (pos. 
1135) 
Histological sections 
After in situ hybridisation, the skin pieces were embedded in Technovit 7100 
(Heraeus Kulzer GmbH, Wehrheim, Germany), according to the manufacturer’s 
instructions. In some cases, the tissue was first decalcified in Osteosoft® (Merck 
KGaA, Darmstadt, Germany) for 24 h before embedding. Sections were cut at 
5µm, counterstained with neutral red and cover-slipped with Permount™ 
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(Fisher Scientific, Fair Lawn, New Jersey). The imaging was done with Nikon 
eclipse E800M equipped with DSF1 camera. 
Plasma membrane staining 
Whole-mount prefixed adult zebrafish scales were stained with Concanavalin A 
(ConA) FITC conjugate Type 4 (Sigma-Aldrich, St. Louis, USA) for membrane 
glycoproteins [209]. Scales were incubated in Con A FITC (25 µg/ml) for 10 min 
and then counterstained with DAPI nuclear stain (5 µg/ml for 2-3 min; 
Invitrogen, Carlsbad, USA). Confocal imaging was done using a Zeiss observer 
LSM 500. 
Quantitative analysis of mmp-9 positive cells 
The total number of mmp-9 positive cells was counted in the serial sections of 
whole mount in situ hybridised scales on skin. Each section was 5µm thick and 
the total number of serial sections selected for counting was the same for each 
group (control, 2day regenerated and 4day regenerated). The mmp-9 positive 
cells were counted under a Nikon eclipse E800M microscope. Cell numbers 
were expressed relative to ontogenetic scales and statistically tested by means 
of a Mann-Whitney U test. 
Anti zf-MMP9 and TRAcP double staining 
Ontogenetic and regenerating scales (8 days) were fixed for 30 min in 4% 
paraformaldehyde in PBS at 4oC and subsequently washed with PBS. Whole 
scales were incubated for 1 hour with block buffer (1% normal donkey serum in 
PBS) and subsequently incubated overnight at room temperature with zebrafish 
anti-MMP-9 (Anaspec, Fremont, USA) at a dilution of 1:100 in block buffer. 
Next, scales were rinsed three times with PBS and incubated at room 
temperature with biotinylated anti-rabbit IgG (Vector Laboratories, Burlingame, 
USA) in blockbuffer at a dilution of 1:200 for 1 h. Scales were again rinsed three 
times with PBS and MMP-9 was visualised with Vectastain ABC kit (Vector 
Laboratories, Burlingame, USA) according to manufacturer’s instructions for 
staining with nickel-diaminobenzidine (Ni-DAB). Scales were subsequently 
stained for TRAcP activity according to the method described by van de 
Wijngaert & Burger (1986) [210].Nuclei were stained with haematoxylin. 
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Dissected skin parts, with scales embedded, were subjected to TRAcP staining 
only. 
qRT-PCR 
Total RNA was isolated from regenerating scales and ontogenetic scales 
using Trizol (Invitrogen, Carlsbad, USA) according to manufacturer’s 
instruction and subsequently treated with DNase I (Invitrogen). cDNA 
was synthesised using Superscript Reverse Transcriptase II enzyme 
(Invitrogen) according to manufacturer’s instructions. Thus obtained 
cDNA was 10x diluted in ultrapure water for quantitative PCR.  
Quantitative PCR was done according to Gorissen and co-workers [211]. Primer 
sequences for the different target genes are listed in table 1. The expression 
levels of the housekeeping genes β-actin and 40S were combined in an index 
using the software tool BestKeeper [212]. Expression of mmp genes was 
corrected for primer efficiency and reference genes, and plotted relative to 
expression in ontogenetic scales collected on day 0.  
Gelatin Zymography 
Activity of putative matrix metalloproteinases 2 and 9 was detected with 
gelatin zymography. Ten ontogenetic and 10 regenerated zebrafish scales were 
cultured for 20 h in 100 µl MEMα (Invitrogen). Zymography was done according 
to Bildt and co-workers [213]. Relative MMP activity was calculated from band 
intensity with Quantity One software (Bio-Rad, Hercules, USA) and related to 2 
ng human recombinant proMMP-2.  
GM6001 exposure 
GM6001 (ilomastat) from Millipore (Billerica, USA) was dissolved in DMSO at a 
concentration of 1 mg/ml. From two groups of six fish each, approximately 50 
scales were removed from the left side of the fish. To specifically investigate 
MMP activity during scale plate Remodelling, GM6001 exposure (100 nM) was 
started at day 2 in one group while the other group was exposed to the vehicle. 
Water was replaced every other day. On day 4 and day 7, three fish from each 
tank were sacrificed.   




Medium from overnight scale cultures was concentrated approximately fivefold 
by vacuum drying. Samples were loaded on a SDS-PAGE gel according to 
standard procedures. Proteins were transferred to an Immobilon-P PVDF 
membrane (Sigma-Aldrich) and used for Western blot with anti-MMP-9 
(Anaspec) at a dilution of 1:1000. Biotinylated anti-rabbit IgG (Vector 
Laboratories, Burlingame, USA) was used as second antibody at a dilution of 
1:1500. The Western blot was developed with Vectastain ABC kit (Vector 
Laboratories) according to manufacturer’s instructions for staining with nickel-
diaminobenzidine (Ni-DAB). 
Hydroxyproline assay 
Twenty scales (ontogenetic or 6 days regenerating) were taken from 6 fish and 
cultured overnight in 200 µl MEMα. Collected culture medium was mixed with 
400 µl 100% ethanol and allowed to precipitate overnight. Samples were 
centrifuged 15 min at 1710g and supernatants were collected. Pellets were 
washed with 200 µl 70% ethanol and supernatants were added to previously 
obtained supernatants. Samples were dried in a hot stove and then 
resuspended in 50 µl 2M NaOH. Samples were autoclaved for 30 min and 
hydroxyproline was measured according to the method described by Reddy and 
Enwemeka [49]. 
Results 
mmp-9 gene expression in ontogenetic scales 
In ontogenetic (non-plucked) scales of adult male zebrafish, mmp-9 expression 
was confined to cells on the episquamal side, along the radii and margins of the 
scale (see Fig. 1 A, B and D for whole-mounts and Fig. 1 C and E for histological 
sections). Scleroblasts on the hyposquamal side showed no hybridisation; the 
mmp-9-positive cell population was confined mainly to the episquamal surface 
of the scale and included both mononucleated cells (Fig. 1 C and D) and 
multinucleated cells (Fig. 1 B, E). Fig. 1 F shows a superimposed confocal image 
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of plasma membranes stained with concanavalin A FITC conjugate. No separate 
plasma membranes were seen dividing the cytoplasmic mass of cells similar to 
the mmp-9 expressing cell in Fig. 1 B.  However, the nuclear membranes of the 
five nuclei were distinct. The extent and position of these marginal cells varied 
between individual scales on the same fish, and between scales from different 
fish, and were absent in some scales. Despite this irregular distribution, the 
differences in expression as a result of scale regeneration are far more 
pronounced.  
 
Fig. 1. In situ hybridization of zebrafish mmp-9 on whole ontogenetic scales and in 
histological sections. A whole mount ontogenetic scale, arrowheads indicate the 
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positive clusters on the scale margins; bar = 300 µm. B  Another ontogenetic scale 
showing mmp-9
 
positive cells on the margin and radii of the scale; bar = 100µm. C 
Section of an ontogenetic scale, showing the mmp-9 positive marginal cells 
(arrowhead); bar = 100 µm. D Multinucleated cell(s) expressing mmp-9 on the radii (r) 
of an ontogenetic scale; bar = 10 µm. E Section of an ontogenetic scale with a 
multinucleated cell (arrowheads) on the episquamal side (towards top of picture); bar = 
50 µm. F Superimposed Z-stack confocal image of ConA-FITC (green) stained cell on 
scale margin with nuclei counterstained with DAPI (blue); bar = 10 µm. 
mmp-9 gene expression in regenerating scales 
In sectioned whole mounts of 2 days regenerated scales, mmp-9 transcripts 
were present in cells scattered on the episquamal, mineralised side of the 
newly-formed scale matrix (Fig. 2 A and B). These cells were predominantly 
mononucleated. However, after 4 days of regeneration, mmp-9 expressing cells 
were more abundant in sections (Fig. 2 C). The 4 days regenerated scales 
possess aggregates of cells which appear by light microscopic observations to 
be multinucleated in sections. In the sections of 4 days regenerated scales, the 
collagenous matrix was thinner than that of ontogenetic scales and radii had 
not yet formed. In both 2 and 4 days regenerated scales there were no 
multinucleated marginal aggregates as seen in ontogenetic scales. In the 
sections of 8 days regenerated scales, mmp-9 expression was similar to that of 
4 day regenerated scales (Fig. 2 D). There were single cells expressing mmp-9 all 
over the entire scale. Multinucleated mmp-9 expressing cells were also present 
(Fig. 2 E). Quantification of the number of positive cells reveals that there are 
fewer mmp-9 positive cells on day 2, but their numbers are increased on day 4 
(Fig. 3).  
MMP-9 & TRAcP double-staining 
Staining on scales embedded in the skin clearly depict TRAcP postive cells along 
the margins of all scales (Fig. 4 A). Ontogenetic scales show positive staining for 
TRAcP activity on the episquamal side, predominantly along the radii (Fig. 4 B). 
At higher magnifications, MMP-9 positive cells can also be detected (Fig. 4 C 
and E), some of which were located in close vicinity of resorption pits. Some 
mononuclear osteoclasts along the the radii show colocalisation of MMP-9 and 
TRAcP (Fig. 4 D). On regenerating scales, the TRAcP activity appears increased 
and irregularly spread compared to ontogenetic scales (Fig. 4 E). Mononuclear 
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osteoclasts that both express MMP-9 and secrete TRAcP were seen along the 
grooves of the scale (Fig. 4 F). At more irregular areas of TRAcP staining, 
multinuclear osteoclasts with MMP-9 immunoreactivity appeared to be present 
as well (Fig. 4 G). 
 
 
Fig. 2. Regenerating zebrafish scales, hybridised in situ as whole mounts with mmp-9 
probe, and then sectioned. A, B, Sections through the skin with 2 day regenerating 
scales. Mononucleated cells positive for mmp-9 are situated on the newly-deposited 
matrix (arrowheads); m = melanocyte; bars in A and B = 50 µm. C Section through the 
skin and scale at 4 days regeneration. Numerous positive cells are distributed along the 
whole scale; bar = 100 µm. D Section through the skin with an 8 day regenerating scale, 
showing mononucleated mmp-9 positive cells (arrowheads) at the radii; bar = 100 µm. E 
Section through 8 day regenerating scale showing mmp9 positive cells lying on the 
episquamal surface of the newly-formed scale matrix (indicated by the bracket and 
asterisk). m, melanocyte; bar = 25 µm. 
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qRT-PCR profiling of mmp-2 and mmp-9 expression 
Expression of the mmp-2 and mmp-9 genes in ontogenetic and regenerated 
scales is illustrated in Fig. 6. Note that scales could not be collected earlier than 
4 days of regeneration because of their small size. In 4 day regenerating scales, 
mmp-2 expression is increased compared to ontogenetic scales (Fig. 5A). On 
days 5 and 8 of regeneration, mmp-2 expression is significantly increased (by as 
much as fourfold). Expression of mmp-9 is already up-regulated significantly 
after 4 days, and remains up-regulated until day 8 (Fig. 5 B). After 2 weeks, 
expression of both mmp genes has returned to levels seen in ontogenetic 
scales. 
Zymographic analysis 
The medium from an overnight culture of scales demonstrates the presence of 
several molecular species with gelatinolytic activity (Fig. 6). To identify the 
molecular species and normalise the MMP activity, human recombinant MMP-2 
and -9 were loaded in lanes 1 and 2, respectively. The largest molecular species 
secreted by scale cells, can be identified as the inactive proMMP-9, which has 
been activated after electrophoresis by autocatalysis. The gelatinase with a 
weight of approximately 77 kDa, has been confirmed to be active MMP-9 with 
Western blot (Fig. 6). The other two clear bands are predicted to be MMP-2, 
the other matrix metalloproteinase with a preference for gelatin. Both the 
latent form (approximately 67 kDa) and the active form (approximately 59 kDa) 
of zebrafish MMP-2 are several amino acids smaller than their mammalian 
counterparts [214]. The faint and heavy bands located around 150 kDa are most 
likely MMP-dimers, which are normally observed in zymographies [215].  




Fig. 3. Analysis of the number of mmp-9 expressing cells in 2 and 4 days regenerating 
scales compared to ontogenetic scales. Significance compared to ontogenetic scales 
was calculated by means of a Mann-Whitney U test. Bars represent the mean value, 
error bars indicate S.D. (N=68-116, **: P<0,01; ***: P<0,001). 
 
 
Fig. 4 Whole skin TRAcP staining (A) and MMP-9immunocytochemistry (black) 
combined with enzymatic TRAcP staining (red) in ontogenetic (B, C, D) and 8 day 
regenerating scales (E, F, G). A Overview of ontogenetic scales in the skin with stained 
for TRAcP. Positive cells are found along the margins (arrow heads), scale bar = 500 µm. 
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B overview of an ontogenetic scale with TRAcP staining along the radii (arrows); bar = 
250 µm C MMP-9 positive cells (black arrows) with minimal TRAcP staining in a typical 
resorption pit (white arrow) along a radius; bar = 50 µm. D mononucleated osteoclast 
with MMP-9 immunoreactivity (arrow) along a radius; bar = 50 µm. E overview of a 
regenerating scale with irregularly distributed TRAcP positive areas (arrows); bar = 250 
µm F Typical MMP-9 positive cells with TRAcP secreted into the surrounding matrix 
(arrow) ; bar = 50 µm.  G Typical multinuclear cells (arrows) positive for TRAcP and 
MMP-9. Note that nuclei are smaller in these cells; bar = 50 µm. 
 
Fig. 5. rtQ-PCR. A expression of mmp-2 in ontogenetic and regenerating scales. B 
expression of mmp-9 in ontogenetic and regenerating scales. The solid bar represents 
the expression in ontogenetic scales. Significance was calculated by means of a Mann-
Whitney U test. Points represent the mean value, error bars indicate S.E.M. ( N=5, *: 
P<0,05; **: P<0,01). 
 
The total amount of secreted gelatinases is increased in regenerating scales. 
Especially the activity of the lightest molecular species (active MMP-2) had 
increased, and the inactive proMMP-9 disappeared (Fig. 7A). An analysis of the 
intensity of the bands sheds more light on the changes in gelatinases expressed 
in ontogenetic and regenerating scales (Fig. 8). As mentioned above, no bands 
of 87 kDa could be detected in the regenerating scales. Significantly more of the 
putative active MMP-2 and MMP-9 were present in the culture medium of 
regenerating scales. The amount of latent MMPs remained the same (67 kDa), 
or decreased (87 kDa).  
The zymographic analysis of the scales from fish exposed via the water to 
GM6001 show clear differences between exposed fish and the control group 
(Fig. 7B). Although the scales have not been subjected to GM6001 during 
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culture, the in vivo GM6001 exposure resulted in bands of lower intensity 
compared to the control group.  
Hydroxyproline assay 
The modified amino acid hydroxyproline was used as a measure of matrix 
degradation. In culture medium of ontogenetic scales, hydroxyproline could not 
be detected. However, it could be detected in the culture medium of 6 day 
regenerating scales at a level of 0,2 ± 0,17 ng hydroxyproline per scale, which 
indicates increased matrix degradation in regenerating scales. 
 
Fig 6. Anti-zfMMP-9 Western blot (left) and zymogram (right) of the same medium 
sample from an overnight scale culture. The same band of 77 kDa is observed on the 
Western blot for MMP-9 and the zymogram. MMP complexes are also observed. 
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Fig. 7. A Zymographic analysis of medium from overnight scale cultures. The positive 
controls (human recombinant proMMP-2 and proMMP-9 are shown in the first two 
lanes. Lanes 3 to 6 show the gelatinolytic activity of MMPs excreted by ontogenetic 
scales. Lanes 7 to 11 show an increase in gelatinolytic activity of MMPs secreted by 
scales after 6 days of regeneration. B Zymographic analysis of 4 and 7 day ontogenetic 
and regenerating scales from fish exposed to GM6001 or vehicle. Gelatinolytic activity 
was attenuated in all groups of fish exposed to GM6001. 
 
Fig 8. Semi-quantitative analysis of gelatinolytic activity on ontogenetic (closed bars) 
and regenerating (open bars) zebrafish scales. ND, not detectable. Bars represent mean 
values, error bars indicate S.E.M. Increase in the putative active MMPs tested for 
significance by means of a Mann-Whitney U test, N=4-5 (** P<0,01; ***P<0,001). 
Discussion  
We have shown both by in situ hybridisation and immunocytochemistry the 
presence of mononucleated and multinucleated mmp-9 positive cells on the 
episquamal side of adult zebrafish (regenerating) scales. Plasma membrane 
staining and TRAcP - MMP-9 double staining identified these cells as 
osteoclasts. We found an increase in expression of mmp genes, cell abundance, 
activity of MMPs and hydroxyproline levels during scale regeneration. These 
results combined confirm that MMPs and anticipated osteoclasts play an 
important role in scale resorption and Remodelling.  
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Although many other types of cells, such as fibroblasts and macrophages, are 
known to express mmp-9 [216], the epidermis that covers the scale is 
completely devoid of mmp-9 expressing cells. The wound that results from 
scale removal closes within two h [101]. This is an important notion as it 
confirms that gene expression and enzymatic activity reported here is not from 
inflammatory cells, but exclusively from scale cells.  
The in situ hybridisation study revealed both mono- and multinucleated cells 
expressing mmp-9 transcripts. To provide a better picture of the nature of these 
cells, scales were stained for plasma membranes and TRAcP. Double staining for 
TRAcP and MMP-9 shows that these two osteoclasts markers are usually co-
expressed. This is found for both the marginal and episquamal cells and defines 
these positive cells as osteoclasts. Indeed, mononucleated osteoclasts have 
been described in other thin zebrafish skeletal elements [26]. Inside the 
multinucleated aggregates, we did not see plasma membranes which prove 
that they are indeed multinucleated osteoclasts. They were found on both 
ontogenetic and regenerating scales. Our finding of mono- and multinucleated 
osteoclasts, expressing both MMP-9 and TRAcP, provides further insight into 
the process of scale regeneration [101,200]. This is significant because TRAcP is 
considered to be a marker for osteoclasts able to resorb bone, as judged from 
“resorption pits” seen next to these cells. 
The expression of mmp-9 that we have found in marginal cells of ontogenetic 
scales is possibly related to the normal growth of scales that continues 
throughout the fish’s growth. The irregular distribution of positive cells along 
the margins of ontogenetic scales shows that growth does not take place along 
the entire margin at the same time but is probably confined to different spots. 
Another explanation for these cells could be that they repair the normal wear-
and-tear of individual scales. Cells expressing mmp-9 transcripts are also found 
along the radii, where most areas of scale resorption are found. The hypothesis 
that radii are primary sites of calcium and phosphorus recruitment is supported 
by the presence of blood vessels above the radii enabling transport of those 
minerals [198]. Since we found no staining of cells on the hyposquamal surface, 
it is reasonable to conclude that hyposquamal scleroblasts, which have 
osteoblast-like characteristics [108], do not express mmp-9.  
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Both in situ hybridisation and quantitative PCR show that mmp genes are 
significantly up-regulated in regenerating scales from day 4 onwards. 
Interestingly, on early regenerating scales (2 days), only a few, mononucleated 
mmp-9 positive cells are present on the new scale. At this point in regeneration, 
the first collagen matrix is deposited and has just started to mineralise (de 
Vrieze, unpublished data). There are no marginal mmp-9 positive cells during 
early regeneration, likely due the complete new-formation of the scale. The 
increase in mmp-2 and mmp-9 expression is at its maximum around day 5. At 
this time, the scale plate has formed and the focus is already mineralised (de 
Vrieze, unpublished data). Histology revealed that on day 4 and 8, both mono- 
and multinucleated osteoclasts are present on the scale matrix. This coincides 
with the increased mmp expression and the initiation of scale plate 
Remodelling. After 10 to 14 days, expression of the mmp-2 and mmp-9 genes 
declines and returns to levels seen in ontogenetic scales. The scale plate is now 
formed and mineralised to its full extent, and will be remodelled to its original 
design [101].   
To further establish the role of MMPs in scale regeneration, we investigated 
here the secretion of these proteins by scale cells. Our results show that the 
increase in secreted MMP activity in the medium by means of gelatin 
zymography correlates with the up-regulation in gene expression during scale 
regeneration. A significant increase is observed in putative active forms of the 
two gelatinases. The amount of latent proMMP in the medium remains the 
same or decreases, indicating that more MMPs are activated. The inhibition of 
MMP activity by in vivo exposure to the MMP inhibitor GM6001, further 
underlines the parallels between zebrafish and mammalian MMPs. The 
preferred substrates of active MMPs are gelatin, a product of collagen 
degradation, and to a lesser extent, native collagen. The switch to higher MMP 
activity indicates an increase in gelatin degradation and thus an increase in 
scale matrix degradation. As there are other substrates for MMPs [39], 
additional roles of MMPs in scale regeneration cannot be excluded by our 
findings. In mammalian bone development, MMP-9 also regulates 
bioavailability of growth factors [40]. Nothing is known about the presence of 
growth factors on scales, but collagen and its degradation products (e.g. 
gelatin) are present to a large extent in the scale matrix [105]. The release of 
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hydroxyproline from regenerating scales confirms that the scale matrix is 
indeed degraded during regeneration as a result of Remodelling. Our data 
suggest that matrix proteolysis is an important function of matrix 
metalloproteinases during scale regeneration.  
Conclusions 
The gelatinases MMP-2 and MMP-9, expressed in mono- and multinucleated 
osteoclasts, play a pivotal role in the regeneration of zebrafish scales. These 
enzymes are specialised in degradation of extracellular matrix, and are likely to 
be involved in the Remodelling and organization of the scale surface, probably 
by shaping the radii and circuli. In mammalian bone of dermal origin, MMPs 
also function in the osteoclastic degradation of matrix. As a result of these 
parallels, scales may offer a valuable model to study the underlying 
mechanisms of osteoclastic bone resorption [217]. Their small size, short 
regeneration time and possession of cells that express important osteoblast 
and osteoclast markers, could make them particularly suitable for applications 
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Chapter 5: Acute exposure to 
dexamethasone in early-life is 
associated with enduring effects on 
wound healing in zebrafish larvae  
Abstract 
The goal of this study was to assess the impact of an acute but brief DEX 
exposure in early-life (prim-6 stage) on the ability to repair damaged tissue 
following amputation of the caudal fin at later life stages including 5 and 14  dpf 
in zebrafish larvae. We show that prior history of DEX exposure, that is not 
concomitant with an injury sustained later in life, significantly impairs wound 
healing long after DEX has been washed out at both life stages studied. We also 
show that DEX-induced impairments in wound healing can however be fully 
restored to normal levels with longer post amputation recovery time.  
Analysis of the several outcome measures taken in this study including cell 
proliferation, cell death (necrosis and apoptosis), gene expression, and 
leukocyte cell marker (L-plastin) suggest that DEX exerted its effects in the early 
phase (4 h) of wound healing rather than in the later phases of the tissue repair 
process. A main event include massive amount of cell death both by necrosis 
and apoptosis at 4h post amputation, which is not compensated, at least as far 
as 24 h post amputation. The concomitant significant reduction in the number 
of L-plastin positive/leukocyte cells observed at 4 h post amputation suggest 
that these cells may have been among the large amount of cells lost via 
necrosis and apoptosis. Therefore, it is likely that DEX-induced reduction in the 
number of L-plastin positive/leukocytes observed in this study may not only 
have altered the clearance of cell debris but also lowered levels of growth 




contribute to impede the initiation of the blastema formation and its 
progression, and results in impaired wound healing.  
In sum, this study provides evidence that DEX exposure during early sensitive 
periods of development appears to cause permanent alterations in the 
cellular/molecular immune processes that are involved in the early phase of 
wound healing in zebrafish. These findings are consistent with previous studies 
showing that antenatal course of DEX are associated with immediate and 
lasting alterations of the immune system in later life in rodents, non-human 
primates, and humans. Therefore, the findings presented in this study support 
the use of the larval zebrafish as a valid model to study the impact of stress and 
stress hormone exposure in immature organisms on health risks in later life.  
Introduction 
Stress and wound healing 
A large core of epidemiological data shows the pervasive effects of both major 
and minor stressful life events on health including the worsening of existing 
illnesses [218-221]. One manifestation of this phenomenon is the impact of 
psychological stress on wound healing in humans. Several studies have clearly 
demonstrated the slowing of wound healing by psychological stressors 
including marital conflicts/hostility [221], examination stress [222], and caring 
for a relative afflicted with a debilitating disease [221]. Complex interplays 
between the neuroendocrine and immune systems mediate these effects 
[3][218,223]. One immediate function of the immune system during the early 
phases of wound healing is to sterilize the wound area and remove dead cells 
and bacteria. Once the wound has been cleared of debris, cells of the immune 
system (neutrophils, and leucocytes) play a key role in secreting a wide range of 
molecules (e.g. TGFα, TGFβ1, TGFβ2, TGFβ3, FGF, PDGF, IL-1,IL-4,IL-8,G-
CSF,GM-CSF) that favour subsequent migration and division of cells involved in 
the proliferative phase of wound healing, just proximal to the injured site, and 
which results in tissue outgrowth replacing the damaged structure [1] (Table 1). 
Progress in the understanding of the interplay between the stress and immune 
systems revealed that stress, via the stress hormone glucocorticoid (GC) 
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(cortisol in humans and fish, and corticosterone in rodents), exerts significant 
detrimental effects in the early phases of the inflammatory response [224]. 
Specifically, both stress-induced up-regulation of GCs as well as synthetic GC 
exposure have been shown to impacts the early phase of wound healing (within 
4 h) by decreasing the number of immune cell types such as neutrophils, 
leukocytes, and macrophages recruited at the wound site as well as by down-
regulating the expression of their secreted factors such as interleukin 1 
(IL-1),interleukin-4 (IL-4),interleukin-5(IL-5), interleukin 8 (IL-8), 
chemokynes, cytokines and tumour necrosis factor- α (TNF-α)  [225,226]. 
Globally, these GC-mediated events are believed to underlie the slowing 
of wound healing [218,227]. Conversely the stress-reduction intervention 
programs have been shown to up-regulate several components of the early 
immune response, and greatly accelerate wound healing in humans [218], thus 
confirming the importance of the GC pathway in wound and tissue repair.  
Antenatal glucocorticoid exposure and enduring 
consequences on immunity 
In parallel, exposure to various stressors and synthetic CGs in early life also 
trigger significant and enduring effects on both the neuroendocrine and 
immune systems [218,228-231]. One prominent example is the clinical practice 
consisting of administering the synthetic GC dexamethasone (DEX) during late 
gestation in situations where risks of premature deliveries are elevated [232-
237]. This procedure is meant to promote foetal lung maturation and treat 
inflammatory complications of the respiratory system of newborn infants [238-
240]. Though to be safe, this procedure was found to be associated with a host 
of side effects with far reaching impact on physical and mental health 
throughout the lifespan [5]. Relevant to the current study, antenatal DEX 
exposure has been associated with enduring consequences on immunity in two 
important ways: 1) long-lasting alterations of the stress-regulating system 
(referred to as the hypothalamic-pituitary-adrenal (HPA) axis leading to 
conditions of GC resistance (via decreased GC function or GR number and/or 
function) has been shown to impair immune responses in adulthood [223]. 
Immediate interference with thymus development leading to enduring changes 




production [241,242], as well as predisposition to autoimmune disorders [242]. 
These findings suggest that exposure to stress and GCs during development 
exerts programming effects on the immune system, which may account to 
explain individual differences in the ability to deploy adequate immune 
responses in later life. In the present study, we have investigated the impact of 
DEX exposure during early development on later ability to repair tissue damage 
in zebrafish.  
A novel model of wound healing in zebrafish: the caudal fin 
amputation paradigm 
Because lower animals like urodeles and amphibians and many invertebrates 
have retained their regenerative capabilities to a remarkable extent throughout 
evolution, they have been widely used to deepen our understanding of the 
processes underlying wound healing and tissue regeneration. This is in sharp 
contrast with humans and other vertebrate species, which have retained a 
much less spectacular regenerative capacity, which is mostly restricted to the 
liver and fingertips [6,7]. One exception is the zebrafish, a vertebrate species 
endowed with a remarkable capacity to regenerate their fins, optic nerve, 
scales, heart, and spinal cord [2,243,244]. Over the last decade, the zebrafish 
has become a model of choice to investigate molecular pathways involved in 
regeneration and relevant to those of higher vertebrates, including humans 
[2,197,245]. One of the well-established zebrafish models of tissue 
regeneration is the caudal fin amputation model. This procedure consists of 
amputating the caudal fin at the neural keel, without touching the notochord. 
This procedure is typically performed on 2 day-old embryos [12]. By the third 
day post amputation (dpa), larval zebrafish can fully regenerate and replace 
their lost caudal fin including its shape, size, and structure, which become 
undistinguishable from that of intact larvae of an equivalent life stage [121]. 
Caudal fin regeneration involves three overlapping steps that are depicted on 
table 1 and including: 1) wound healing (0–3 h), 2) blastema formation (4–6 h), 
and regenerative outgrowth, which is divided into an early phase (6-24 h) and 
late phase (24-48 h). Within 10 min of the wound healing process, epithelial 
cells begin to migrate over the injured site, where the wound is sealed with 
actin-purse ring structure. During the blastema stage, cells proximal to the 
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amputation site initiate a process of dedifferentiation and become momentarily 
pluripotent cells with the capability to proliferate and differentiate into the 
various cell types required to regenerate lost tissue [119,120]. The process of 
cell proliferation and differentiation, gradually leads to tissue outgrowth and 
eventually to a full recovery of the lost tissue by 3 dpa [121].  
It is noteworthy that the caudal fin amputation model can be as reliably 
performed in both larval and adult zebrafish since the molecular mechanisms of 
tissue regeneration comprising all cell types (e.g. four cell types in wound 
epidermis, three cell types in blastema and one mmp-9 expressing cell type) 
[117] and key molecules (listed in Table 1), which are strikingly similar between 
larval and adult zebrafish. These qualities make the larval zebrafish model of 
caudal fin amputation especially attractive for forward genetic and high-
throughput screening of molecules modulating the processes involved in tissue 
regeneration [121]. 
Goal of the study 
Understanding the mechanisms by which stress and stress hormones slow the 
wound healing process and delay tissue repair is important. While GCs are 
known to be potent suppressors of tissue repair in acute exposure regimen 
concomitant with injury in several animal models [223], relatively little is known 
about the impact of acute GCs exposure prior (in early-life) but not concomitant 
with injury (later in life) on the individual’s ability to repair damaged tissue. To 
address this issue, we assessed whether synthetic GCs (i.e. DEX) acutely 
administered prior but not concomitant with the caudal fin amputation 
procedure would also impair abilities to repair damaged tissue in the larval 
zebrafish model. Specifically, we performed the following steps: 1. We assessed 
the impact of early-life (stage prim-6) acute DEX exposure on the subsequent 
ability to repair damaged tissue following the caudal fin amputation procedure, 







Table 1   Schematic representation of regeneration 
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(Experiment 1) and 11 days (Experiment 2) following initial exposure to DEX. In 
both groups, a 2 day-post amputation recovery period was given after which 
the extent of tissue damage/repair was measured. 
2. We also assessed whether the impairing effects of early-life DEX exposure on 
tissue repair processes observed in experiment 1 would be restored to levels 
comparable to that of controls if given longer post amputation recovery period. 
This was achieved by allowing longer recovery time following caudal fin 
amputation. In this group the extent of tissue damage/repair was assessed 
much later following amputation, i.e. 11 days (experiment 3). Note that this 
experiment could not be performed on individual older than 14  dpf 
(experiment 2) due to technical difficulties. 
3. In order to get insights into the mechanisms underlying the lasting effects of 
DEX on tissue repair processes observed in experiment 1, we have taken the 
following endpoint measurements: 1) size of the regenerated area of the caudal 
fin, 2) analysis of a panel of regeneration-related genes (msxb, wnt3a, rarg, 
hoxd11, GR and MR) via qRT-PCR, 3) cell death (Tunnel and acridine orange), 4) 
cell proliferation assay (BrDU), and 5) quantitative analysis of immune cells 
invasion at the wound site using immunohistochemistry against L-plastin, a 
macrophage and leukocyte marker.   
Materials and Methods 
Statement of ethics on animal use 
All experimental procedures were conducted in accordance with The 
Netherlands Experiments on Animals Act that serves as the implementation of 
"Guidelines on the protection of experimental animals" by the Council of 
Europe (1986), Directive 86/609/EC, and were performed only after a positive 
recommendation of the Animal Experiments Committee had been issued to the 
license holder. 
Zebrafish maintenance 
Male and female adult zebrafish (Danio rerio) of AB wild type were purchased 




stock from Europet Bernina International BV (Gemert-Bakel, The Netherlands). 
Fish were kept at a maximum density of 12 individuals in plastic 7.5 L tanks 
(1145, Tecniplast, Germany) containing a plastic plant as tank enrichment, in a 
zebrafish recirculation system (Fleuren & Nooijen, Nederweert, The 
Netherlands) on a 14 h light: 10 h dark cycle (lights on at 7h AM: lights off at 21 
h PM). Water and air temperature were maintained at 24 oC and 23 oC, 
respectively. Fish were purchased at the juvenile stage and were allowed to 
adapt to our facility for at least 2 months before being used as adult breeders. 
The fish were fed daily with dry food (DuplaRin M, Gelsdorf, Germany) and 
frozen artemias (Dutch Select Food, Aquadistri BV, The Netherlands).  
Zebrafish eggs were obtained by random mating between sexually mature 
individuals. Briefly, on the day (16h) before eggs were required, a meshed net 
allowing eggs to pass through but preventing adult fish from accessing/eating 
them, was introduced in the home tank of a group of 12 adult fish. Each 
breeding tank was only used once per month to avoid handling stress and 
ensure optimal eggs quantity and quality.  
Selection of the dosage of DEX 
The dosage (1 mM) of water soluble DEX (Sigma Aldrich, Switzerland) used in 
the present study was chosen based on a pilot study where four concentrations 
of DEX, including 100, 250, 500 and 1000 µM were tested on embryos at the life 
stage 25 hpf (equivalent to the prim-6 stage [122] for a duration of 6 h. The 
caudal fin amputation procedure was performed on 3 dpf and assessment of 
regenerative capacity was done on 5  dpf. We found that dosages of 500 µM 
(p< 0.01) and 1000 µM (p< 0.001) of DEX significantly reduced tissue 
regeneration relative to controls (Fig.1 A). Note that no mortality or 
morphological abnormalities (Fig.1 B) were observed between the different 
treatment groups. Therefore, we selected the highest dosage of DEX (1 mM) 
because of its pharmacological safety and largest impact on tissue 
regeneration.  
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DEX Treatment  
The eggs were harvested 30 min after the onset of lights at 7 h AM and age was 
set as dpf 0. This is based on the staging system employed in the zebrafish text 
book untitled Zebrafish: practical approach [43]. Approximately 150 eggs were 
transferred in 10 cm Petri dishes filled with 50 ml of egg water (0.21 g/l Instant 
Ocean Sea Salt and 0.0005% (v/v) methyl blue) and housed in a separate 
climate room maintained at a temperature of 28 °C and 50% humidity and 
under a light-dark cycle of 14h: 10h (lights on at 7h AM/lights off at 21 h PM). 
When all embryos reached the stage prim-6 (25 hpf) they were then transferred 
to 6-well plate (25 embryos/well) and immediately exposed to an acute pulse of 
DEX. DEX treatment consisted of exposing the embryos for 6 h to water-soluble 
DEX (1 mM). At the conclusion of the treatment, the embryos were then 
washed 3 times with egg water and transferred to new clean 6-well plates (30 
embryos/well), where they remained undisturbed for 2 days (experiment 1, see 
details below) and 11 days (experiment 2, see details below). The control group 
was treated according to the same procedure as described above except that 
the DEX exposure step was replaced by egg water only. The larvae were placed 
in the fish facility at 25°C in large tank in egg water till 7 dpf and later on in 
regular water as for adult fish. The tanks were cleaned every day. The larvae 
were fed on baby fish food 2x a day.  
Experimental Procedure 
The timeline and the experimental steps involved in the caudal fin amputation 
procedure are depicted in Fig. 2. Also see section 2.6 for details regarding the 
caudal fin amputation method. In the current study, we have performed three 






Fig. 1 (A) Effect of varying dosages of dexamethasone (DEX) on tissue regeneration. DEX 
treatment was administered at the life stage Prim-6 and lasted 6h. Results show that 
dosages of 500 µM and 1000 µM significantly affected tissue repair. (B) Alcian Blue 
staining shows that DEX treatment (dose 1000 µM) did not cause any morphological 
alterations relative to control treatment. All measures presented in panel A and B were 
performed on 5 dpf larvae. Abbreviations: mc (Meckel’s cartilage), ch (ceratohyal) pa 
(pharyngeal arches), and eye. 
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Experiment 1: The detailed methodology is presented in Fig. 2A. Briefly, 
embryos were exposed to DEX (1 mM) at 25 hpf (prim-6) for 6h. On 3 dpf 
(protruding mouth stage), the embryos were anesthetized with 0.04% Tricaine 
(MS222, Sigma) after which amputation of the caudal fin posterior to neural 
keel was performed with a sharp scalpel (see section 2.6). Immediately after 
amputation larvae were washed 3 times with egg water and then gently 
transferred to new 6-well plates using a Pasteur pipette. A post amputation 
recovery period of 2 days was given after which the extent of tissue 
damage/repair was assessed by measuring a number of outcome measures on 
5 dpf-old larvae (see section 2.7). 
Experiment 2: The detailed methodology is presented in Fig. 2 B. Embryos were 
treated exactly according to the procedure described in experiment 1 with the 
exception that the caudal fin amputation procedure was performed 11 days 
following DEX exposure (i.e. on 12 dpf-old larvae). Following amputation, larvae 
were transferred to new tanks (plastic 7.5 L tanks from 1145, Tecniplast, 
Germany). The post amputation recovery period was the same as in experiment 
1, i.e. 2 days. For this experiment, only the size of the regenerated area was 
measured (see section 2.7.1) 
Experiment 3: The detailed methodology is presented in Fig. 2 C. Since findings 
obtained from experiment 1 showed that acute DEX treatment (1 mM) caused 
significant reduction in tissue regenerative capacity 2 days post amputation 
(measured in 5 d old larvae), we assessed whether the impairing effects of DEX 
on tissue regeneration would recover to a level comparable to that observed in 
DEX-untreated animals with longer post amputation recovery period. To 
achieve this goal, larvae were treated exactly as described in experiment 1 with 
the exception that a longer post amputation recovery period was given, i.e. 11 
days. For this experiment, only the size of the regenerated area was measured 







Fig. 2: Overview of the experimental procedure: (A) Time line of the experimental 
procedures performed in experiment 1. The procedures include DEX (1 mM) treatment 
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at 25 hpf, which lasted 6 h, caudal fin amputation at 72 hpf and termination of the 
experiment at 120 hpf. Analyses 2 and 3 were performed on 96 hpf while analyses 1 
and 3 were done at 120 hpf. (B) Time line of experiment 2 is identical to that of 
experiment 1 with the exception that the caudal fin amputation was performed later on 
288 hpf. Termination of the experiment occurred at 336 hpf. Note that only analysis 1 
was performed at this time point. (C) Time line of experimental 3 was similar to the 
time line of experiment 1 with the exception that the end of the experiment and 
analysis 1 were performed later, i.e. at 336 hpf. (D) Caudal fin amputation procedure. 
The top photograph (control) depicts a typical larva with an intact caudal fin while the 
photograph (tail cut) below depicts a representative example of a larva, which 
underwent the caudal fin amputation procedure. Note that both larvae are 3 dpf. The 
amputation plane was kept near the caudal end of neural keel (boxed area). (E) 
Morphological analysis. The top photograph (Control) depicts a high magnification 
image of normal tail while the middle photograph (Tail cut) depicts a high magnification 
image of the amputated caudal fin. The bottom photograph depicts a representative 
example of a regenerated caudal fin at 5 dpf. Analysis of the regenerated tail was 
performed by outlining the area of the regenerated caudal fin as shown in the 
photograph (see red line). This area is referred to area ‘r’. Measurement of the volume 
of the regenerated area ‘r’ was automatically calculated using image J. Analysis 1 
includes the measurement of regenerated area of amputated caudal fin with image J. 
Analysis 2 includes the necrosis, cell proliferation, and apoptosis assays. Analysis 3 
includes qRT PCR analysis for expression of GR, MR, hoxd11, msxb, wnt3a and RARγ. 
Abbreviations: DEX: dexamethasone, GR: glucocorticoid receptor, MR: 
mineralocorticoid receptor, nc: notochord, cf: caudal fin, N/A: not applicable, hpf: h 
post fertilization.  
Caudal Fin Amputation Procedure 
Caudal fin of 3dpf zebrafish embryos were amputated after anesthetising with 
0.04% MS-222 (tricaine methanesulfonate). The embryos were placed in the 
9cm Petri dish filled with egg water on their lateral side. With a sharp scalpel 
the caudal fin was carefully cut off under a dissecting microscope along the 
amputation plane depicted in Fig 2 C and D. After amputation the embryos 
were transferred 2 x through fresh egg water in separate Petri dishes and then 
to 6well plate till outcome was measured until 5 dpf (experiment 1) and 14 dpf 
(experiment 2 and 3), where the experiment was terminated. The larvae were 






Assessment of Tissue Repair Capacity 
In order to prepare the tissue for morphological analyses, larvae were 
anesthetized with tricaine and then fixed in chilled 4% PFA over night. This 
procedure was equivalently performed for experiments 1 and 2 but at different 
time points depending on the specifics of the experiment, i.e., at 5 dpf 
(experiment 1), and 14 dpf (experiments 1 and 2). Following fixation, the area 
of the caudal fin was imaged under a Nikon eclipse E800M equipped with DSF1 
camera. (Fig.2D). Area of the regenerated caudal fin was outlined as performed 
in Fig. 2D and referred to area ‘r’. Measurement of the regenerated area ‘r’ was 
automatically calculated using image J (National institute of health. See: 
http://rsbweb.nih.gov/ij/). 
Cell Proliferation 
To perform a quantitative assessment of cell proliferation, we used the well-
established cell proliferation marker BrDU [246]. Briefly, larvae were treated 
with BrDU beginning 24 h post amputation until 30  h  post amputation 
according to a protocol described previously [121]. At the conclusion of the 6h-
BrDU treatment, larvae were immediately fixed in 4% PFA at 4 ⁰C over night. 
The tissue was prepared for confocal imaging by undergoing a series of washes 
with phosphate buffers and dehydration steps with methanol (25%, 50%, 75%, 
and 100%). Subsequently, the tissue was stored at -20⁰C until the next day 
where labelling with fluorescent antibodies was performed. The next day, prior 
to immunohistochemical staining the larvae were labelled with anti-BrdU 
antibody (Roche) at a dilution of 1:200 and Alexa flour 534 conjugated anti 
mouse IgG (Molecular probes Eugene) for 2h at room temperature. Tissue was 
maintained at 4⁰C while confocal images were taken for morphological 
assessments. All samples (Veh n=25 and DEX-treated n=25) were processed 
within the same day.  
Necrosis 
For quantitative assessment of necrotic cell death induced by caudal fin 
amputation and/or antenatal exposure of DEX, acridine orange staining was 
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performed to label necrotic cells at 4 h and 24  h  post amputation in both 
control and DEX-treated groups. Acridine orange staining consisted of soaking 
living larvae in a freshly prepared solution of acridine orange stain (200 µM/L 
distilled water) (Schmid and Co, Stuttgart-Unterturkheim, Germany) for 1 hr at 
28⁰C. After several washes with egg water, living larvae were placed into a 
cavity glass slide and covered with a thin cover slip, and then imaged under a 
Zeiss Observer LSM 500. Since acridine orange is fluorescent, necrotic cells 
were visible at an excitation wavelength of 488 nm. Total number of 
fluorescent cells was counted with image J.  
Apotosis 
For assessment of cell death by apoptosis, terminal deoxy-nucleotidyl-
transferase-dUTP nick end labelling (TUNEL) was used. The staining procedure 
consisted of taking fixed (4% PFA) larvae and rehydrating them through graded 
series of methanol, including 75%, 50%, 25% and phosphate buffer (15 
min/solution). Embryos were further washed for 3 time 5 min in phosphate 
buffer (pH 7.4). We used a commercially available TUNEL labelling kit (TACS® 
TdT in situ – Fluorescein, R&D Systems, Inc. 614 McKinley Place NE) and 
followed the manufacturer’s instructions. Images of the caudal tail area for all 
larvae were taken using a Zeiss observer LSM 500 microscope using excitation 
wavelength 488nm. Total number of tunnel-stained cells was counted manually 
from the images.  
Gene Expression 
Gene expression levels were measured by qRTPCR [247]. The protocol, 
methodology and primers (Invitrogen) used for each gene measured in the 
current study are derived from previous work [10,112,137,140,248] (See Table 
1 for sequences).  
 
Table 1.  Primer sequences used for qRT-PCR. 
Primer Nucleotide sequence 5`-3` Reference 




wnt3a dr F 
wnt3a dr R 
TGGGCTCACGCGTGTCATGG 
GCGGAGCTGTTTGGGGACCA 
Shimizu et al 2004 [137] 
ß-actin  F 
















Alsop et al 2007 [249] 
RARγ F 








GAA TTC TCC TAA GGG ACC C 
GATTCAACACTGAACGGGAGG 







Van der Hoeven 1995 [248] 
 
Total RNA was extracted using Trizol® reagent (Invitrogen Life Technologies, 
Belgium) according to the manufacturer’s protocol. Note that for all genes 
studies, the cDNA was taken from the amputated tails and not from the whole 
animal. The following categories of gene were measured: 1) GC receptors (MR 
and GR mRNA) [129], tissue differentiation markers associated with tissue 
patterning (wnt3a and RARγ mRNA) [16,17], and cell proliferation markers 
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(msxb and hoxd11 mRNA) [18]. All genes were measured at two points 
including 24 h and 48  h  post amputation.  
Immune Cell Staining 
The L-plastin immunostaining procedure used in the current study was derived 
from a previous study from Cui and colleagues [191]. Briefly, caudal fin tissue 
was incubated over night at 4°C in blocking buffer containing an antibody 
directed against L-plastin [final concentration 1:500] [181]. Embryos were 
incubated for 2 h at RT in Alexa Fluor 405 Goat-anti-Rabbit (Invitrogen) 1:200 
and were then stored at 4°C and imaged using Zeiss observer LSM 500. 
Statistical Analysis 
Statistical analyses and graphs were performed using GraphPad Prism software 
(version 5.0). One-Way ANOVA analysis was performed to analyze the effects of 
DEX treatment with varying dosages including 100 µM, 250 µM, 500 µM and 
1000 µM on tissue regeneration. A Dunnett’s multiple comparison post-hoc test 
was applied to further decompose group comparisons, where each dosage of 
DEX was compared to the vehicle treatment (DEX 0 µM/egg water). Student T-
tests (two-tailed) were performed to analyze the impact of DEX (1 mM) 
treatment on tissue regeneration (Experiments 1, 2 and 3) as well as to analyze 
the impact of DEX (1 mM) on gene expression and cell proliferation (BrdU). 
Two-Way ANOVA analyses were performed to analyze the data from the 
acridine orange staining, tunnel staining, and L-plastin immunohistochemistry. 
Tukey’s multiple comparison post-hoc tests were applied to further decompose 
group comparisons. Data are presented as mean ± SEM, and a probability level 





Fig. 3 Area of caudal fin (mm
2
) amputated at 3 dpf and regenerated for 48 h. 
Measurements were done with Image J. 
Results 
Experiment 1 
Relative to the control group, DEX-treated embryos displayed significant 
decreases in the total area of the regenerated caudal fin tissue at 2 days post 
amputation (Fig. 3) (p< 0.05).  In order to gain insights into the possible 
mechanisms underlying DEX effects, we have measured the following outcome 
measures including, cell proliferation, necrosis, apoptosis, gene expression, and 
macrophage markers. The results are presented below:  
Cell Proliferation 
Relative to controls, we observed a significant reduction in the number of 
proliferating cells in the regenerating caudal fin in DEX-treated embryos 24 to 
30 hrs post amputation (Fig. 4 A) (p< 0.001). Confocal images confirm that only 
the amount and not the appearance and/or distribution of proliferating cells is 
altered by prior exposure to DEX (Fig. 4 B).  
 
 




Fig. 4 (A) Number of proliferating cells in the regenerated caudal fin after 24-30 hpa is 




cells (red) in the caudal fin region of the regenerating tails of larvae. Number of the cells 
was counted within the boxed area. (C) Number of necrotic cells labelled with acridine 
orange staining after 4h and 24h of amputation. The results show a significant increase 
in cell death in DEX treated larvae as compared to controls. (D) Confocal images of 
(upper left) veh 4hpa and DEX 4hpa (upper right), veh 24hpa (lower left) and DEX 24hpa 
(lower right) showing necrotic cells (green) in the regenerating tail region in living 
embryos. (E) Number of apoptotic cells labelled with Tunel staining at 4hpa and 24hpa. 
(F) Confocal images of Veh 4hpa (upper left) and DEX 4hpa (upper right), 24hpa Veh 
(lower left) and 24hpa dex (lower right) dead cells (green). 
Cell Death 
Analysis of necrotic cell death reveals significantly higher amount of necrotic 
cells in DEX-treated embryos relative to controls both 4  h  (p< 0.001) and 24  h  
(p< 0.001) post amputation (Fig. 4 C). Confocal image analysis showed that, for 
both time points studied, necrotic cells were not aligned within the amputation 
plane but were rather accumulated at the dorsal and ventral corners of the 
regenerating fins (Fig. 4 D). Analysis of apoptotic cell death showed significant 
increases in the number of apoptotic cells at 4 h (p< 0.001) but not 24 h post 
amputation (Fig. 4 E). Confocal image analysis showed that in general the 
apoptotic cells were aligned with the amputation plane but were also present 
in the notochord region. Note that this was only observed at 4 h post 
amputation and appear to have returned to control levels by 24 h post 
amputation (Fig. 4 F).   
Gene Expression 
We observed that, while the expression of the GR receptor mRNA (MR and GR) 
(Fig. 5 A and B) and proliferations markers mRNA (msxb and hoxd11) (Fig. 5C 
and D) were not significantly altered by prior exposure to DEX, significant 
changes in the expression levels of genes involved in tissue patterning (wnt3a 
and RARγ) were observed in DEX-treated embryos relative to controls (Fig. 5E 
and F). Specifically, we observed a significant up-regulation of wnt3a in DEX-
treated embryos relative to controls at 24 h (p< 0.05) but not 48 h post 
amputation (Fig. 5 E). We also observed a significant up-regulation of RARγ 
mRNA levels in DEX-treated embryos at 24 h post amputation (Fig. 5 F) (p< 
0.05). We observed an opposite effect of DEX on RARγ mRNA levels at 48 h post 
amputation, which were significantly down-regulated (Fig not shown). 





Fig. 5 Column graph showing gene expression relative to β-actin in the regenerated 
caudal fins of veh and DEX treated zebrafish larvae 24 hpa. Note the significant increase 
in expression levels of Wnt3a and RARγ in Dex-treated larvae relative to controls. 
L-Plastin 
We observed a significant decrease in the number of L-plastin positive 
macrophages/leukocytes in DEX-treated embryos relative to controls at 4  h  
but not 24 h post amputation (Fig. 6 A) (p< 0.001). Interestingly, we also 
observed that the spatial arrangement of the L-plastin positive cells differed 
between DEX-treated and control groups at 4 h but not 24 h  post amputation. 
Specifically, confocal image analysis revealed that, while L-plastin positive cells 
are aligned with the amputation plane in controls, they were rather irregularly 
distributed across the regenerated area of the caudal fin in DEX-treated 
embryos (Fig. 6 B).  
Experiment 2 
To assess if prior history of early-life DEX exposure would also affect tissue 
repair capacity at later life stages than that tested in experiment 1, we assessed 





Fig. 6 Graph showing total number of L-plastin immunoreactive (ir) leukocyte cells 
counted from the area demarcated with a box in panel B. Cells were counted at 4 hpa 
and 24 hpa in veh and DEX treated larvae. Note the significant decrease in L-plastin 
positive cell in DEX-treated larvae relative to controls 4hpa but not 24 hpa (although a 
trend towards a decrease is also observed at 24 hpa). (B) Overlay of confocal and 
transmitted image showing leucocytes (blue cells) in the regenerating caudal fin region 
in both controls and DEX-treated larvae at both 4 hpa and 24 hpa.   
 
Experiment 1, we also observed that relative to the control group, DEX-treated 
embryos displayed significant decreases in the total area of the regenerated 
caudal fin 11 days post exposure to DEX (Fig. 7 A) (p< 0.5).  
Experiment 3 
To assess whether the effects of DEX are permanent or transient, we allowed a 
longer recovery time following caudal fin amputation and assayed the embryos 
at 11 days post amputation. We observed that, relative to controls, DEX-treated 
embryos were no longer significantly different from the control group in terms 
of size and shape of the total regenerated area of caudal fin at 11 days post 
amputation (Fig. 7 B). 
 
Chapter 5  
103 
 
                  
Fig. 7 (A) Experiment 2. Graph showing area of regenerated caudal fin in control and 
DEX-treated larvae amputated after 11 days of initial DEX treatment and allowed to 
regenerate for 48h. The result show a significant reduction in the are of the 
regenerated caudal fin in DEX-treated larvae relative to controls. (B) Experiment 3. 
Graph showing the area of the regenerated caudal fin in larvae that were amputated at 
3 dpf and allowed to regenerate until 14 dpf. The results show no significant differences 
in the area of the regenerated caudal fin between controls and DEX-treated larvae 
suggesting that full recovery occurs despite initial impairment with longer post 
amputation recovery period. 
Discussion  
This study investigated the influence of DEX exposure during a sensitive period 
of development (prim-6) on the ability to repair damaged tissue following 
amputation of the caudal fin in the post-hatching period in larval zebrafish. We 
report that early-life history of DEX exposure impairs ability to repair and 
regenerate caudal fin tissue across the first 2 weeks of life, and that significantly 
longer post-amputation periods are required for full recovery. The possible 
mechanisms underlying these effects as well as the implication of these results 
in the field of medicine are discussed below. 
Possible mechanisms 
The wound healing phase (0-3 hpa) 
Analysis of the several outcome measures taken in this study including cell 




leukocyte cell marker (L-plastin) suggest that DEX exerted its effects in the early 
phase (4 h) of wound healing rather than in the later phases of the tissue repair 
process. This is based on our observation of a massive amount of cell death 
both by necrosis and apoptosis at 4 h post amputation. This cell loss does not 
appear to have been compensated, at least as far as 24 h post amputation, 
since cell proliferation was found to be drastically decreased in DEX-treated 
embryos relative to controls at that time. The large amount of cell death may 
be responsible for the significant reduction in the number of L-plastin 
positive/leukocyte cells observed at 4 h but not 24 h post amputation. These 
results are consistent with previous studies showing significant reductions in 
immune cell types (e.g. leukocytes) at the injury site few h following acute 
exposure to synthetic GCs (e.g. DEX) [110,225,226]. 
Reduction in immune cells at the injury site has important implications for the 
wound healing phase. Specifically, the invasion of immune cells including 
leukocytes, macrophages, and neutrophils occurs early (within 4 h) during the 
wound healing process and is essential for clearance of cell debris and foreign 
molecules by phagocytosis [250]. It has been shown that alterations in the 
clearance process may hinder and even prevent subsequent steps to take place 
(e.g. blastema formation) [251]. Therefore, it is possible that a decrease in the 
number of immune cell types such as L-plastin positive/leukocytes may have 
altered the clearance process, which in turn interfered with the initiation of the 
subsequent steps resulting in impaired tissue repair and regeneration. 
Following clearance of cell debris, another important function of the immune 
cells is the secretion of growth factors and cytokines. The presence of sufficient 
amount of growth factors and cytokines is also essential for the initiation of the 
blastema formation and its progression [110]. Therefore, it is likely that DEX-
induced reduction in the number of L-plastin positive/leukocytes observed in 
this study may not only have altered the clearance process but also lowered 
levels of growth factors and cytokines at the injury site. Such events may 
simultaneously contribute to impede the initiation of the blastema formation 
and its progression, and results in impaired wound healing.  
Interestingly, we also observed an aberrant arrangement (i.e. misalignment 
with the amputation plane) of the L-plastin positive/leukocytes at the injury site 
when compared to control situations. These findings suggest that DEX also 
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affected the migration pattern of immune cells towards the injury site, which 
may further contribute to delay the initiation of the blastema formation and 
eventually impair tissue repair. However, the fact that full recovery is possible 
with longer post amputation period suggests that the molecular components of 
the immune system are functional but that the natural time course of their 
actions appears delayed. 
The blastema formation (4-24 hpa) 
Alterations in gene expression patterns in the early phase of the blastema 
formation (24 h) reveal that DEX exposure also impedes the natural progression 
of this phase, although perhaps to a minor extent than the wound healing 
phase (see above). Specifically, we observed a significant up-regulation of 
wnt3a and RARγ genes in the DEX treated embryos after 24 h of amputation at 
the injury site. Both of these genes are actively involved in the Remodelling of 
the epidermal or blastemal tissue. Retinoic acid is a signalling molecule for 
vertebrate pattern formation both in developing and regenerating tissue [136]. 
RARγ mRNA is the prominent RAR transcript found in normal regenerating 
tissue. RARγ is expressed in the distal ends of blastema of regenerating adult fin 
tissue [112]. Wnts are secreted glycoprotiens that play an important role in 
body patterning, cell proliferation, cell differentiation and tumour formation 
[137]. Wnt signalling plays a role in the maintenance and renewal of stem cells 
which are cells that help repair the tissue damage [137]. It is possible that up-
regulation of these genes may have served the purpose of compensating for 
the massive cell death and decreased proliferation observed at earlier phases of 
the wound healing process. However, we did not observed any significant 
differences between groups in the expression levels for gene coding for cell 
proliferation marker (msxb and hoxd11). This may be due to our selection of a 
later time point (24 h) than reported in the literature since a previous study 
showed an upregulation of these genes at an earlier time point (16-24 h) [117]. 
Taken together, these findings confirm that the impact of DEX is more 
prominent in the early phase (4 h) of wound healing and extending to the early 
phase of the blastema formation (4-24 h) since no further differences were 
observed between groups in any of the outcome measures studied at 48h post 





A possible mediator of the impairing effects of DEX on the wound healing 
process may be the immunotoxic properties of DEX on developing organs. For 
instance, lymphoid organs (spleen and thymus) and lymphocytes have been 
shown to be particularly sensitive to GCs, especially in immature organisms 
[230]. A main toxic effect of DEX includes apoptosis of immune cells in thymus 
and spleen. A significant reduction in the size of both immune organs has been 
previously reported in response to antenatal DEX exposure in mammal models 
[229,252]. While both thymus and spleen are not developed before 60 hpf in 
zebrafish, the caudal hematopoetic tissue (CHT) serves as lymphoid organ in 
young larvae as early as 24 hpf [253]. Although not measured in the current 
study, it is possible that a brief exposure to high dose of DEX during early 
development (prim-6, 25 hpf) may have affected the development and/or 
function of the CHT, which in turn may have impacted the production of 
immune cells (e.g. macrophages and leukocytes) in the initial phase of wound 
healing. This possibility is also consistent with our observation of a massive cell 
death (via apoptosis and necrosis) within 4 h post amputation.  
Another possible mediator of the impairing effects of DEX on wound healing 
may be via DEX effects on GR expression levels.  DEX is known (even brief 
exposure) to cause enhanced activity of the adrenal glands, which causes both 
lower lymphocytes proliferation response and decrease sensitivity of immune 
cells to GCs [228-230]. This type of insensitivity is usually related to a down 
regulation of GR. A reduced sensitivity to GCs has been shown to impair 
immune processes in several species including humans, and therefore may have 
contributed to the effects observed in the present study [229,230]. It is 
noteworthy that GR is expressed on immune cells such as macrophages and 
leukocytes in fish [110,254]. Since we did not observe any significant changes in 
both MR and GR expression levels between groups at both 24 h and 48 h post 
amputation (data not shown), this possibility is unlikely to play a major role in 
the current study. However, we do not reject the possibility that changes in GR 
expression levels may exist between groups at the level of certain types of 
immune cells such as macrophages and leukocytes. This possibility remains to 
be tested.  




The findings presented here are in agreement with previous studies reporting a 
link between psychological stress and impaired wound healing in human in 
adulthood [218,220,221]. Transient psychological stressors, like academic 
examinations, marital troubles, caring for a sick relative and depression can also 
slow wound healing [110,218,220,221,228]. Our findings also suggest that not 
only stress (or stress hormones) experienced in adulthood but also during early-
life may influence wound healing at later time points during the lifespan. We 
provide evidence that DEX exposure during early sensitive periods of 
development appears to cause permanent alterations in the cellular/molecular 
immune processes that are involved in the early phase of wound healing in 
zebrafish. In support to this claim, previous studies have shown that antenatal 
course of DEX are associated with immediate [255] and lasting alterations of 
the immune system in later life in rodents, non-human primates, and humans 
[228-230,256]. The current study extends these findings by showing, for the 
first time, a similar phenomenon in zebrafish. Our study also provides a 
demonstration of the immediate functional consequences of a DEX-rendered 
malfunctioning immune system on tissue repair in the juvenile organisms.  
These findings have implications for the field of medicine, especially with 
regard to the clinical practice consisting of administering antenatal course of 
DEX to pregnant women at risk for premature delivery. The results obtained in 
this study contribute to enrich the repertoire of information related to the side 
effects of such procedure, which are needed by medical authorities to assess 
the risks/benefits of these extreme intervention methods for the welfare of the 
developing foetuses and infants.    
Future Studies 
Further studies are required to assess whether blocking the effect of DEX using 
pharmacological antagonism or morpholino against GR would have prevented 
the effects observed in the current study. It may also be possible that the genes 
selected here may have been up or down-regulated at earlier time than the 
time points assessed here. Furthermore, whether early-life DEX-induced 




shown. The results presented in this study argue in favour of this idea since we 
observed that not only the impairing effects of DEX are observed relatively early 
(5 dpf) but also at a much later life stage (14 dpf) suggesting that DEX effects on 
wound healing may endure throughout the lifespan. However, further studies 
are required to ascertain the last claim.  
Concluding Remarks 
Our findings are in agreement with the view that GC exposure during early 
development can influence the embryonic/larval immune system resulting in 
prolonged effects on the immune response related to functional impairment of 
tissue repair after hatching. Therefore, similar to other species like rodents and 
non-human primates, zebrafish larvae also appear particularly sensitive to GC 
treatment in early development. Therefore, the findings presented in this study 
support the use of the larval zebrafish as a valid model to study the impact of 
stress and stress hormone exposure in immature organisms on health risks in 
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Chapter 6: Summary and Discussion 
The aim of this thesis was to investigate the expression, and function of genes 
associated with Remodelling and regeneration in the zebrafish model species. 
Since the zebrafish is emerging as a promising low cost and easy to maintain 
experimental animal model with most of its genome sequence available, it will 
be very useful to carryout high throughput drug and compound analyses, once 
specific disease models are established and validated. 
Here, we studied the role of cell populations, defined by their expression of 
markers, in bone regeneration and Remodelling in zebrafish embryos and adult 
zebrafish scales. We also examined how these processes are disrupted by 
behavioural stress using the case of zebrafish embryonic caudal fin 
regeneration. We used mesoporous silica nanoparticles to carry cytokines, 
known to activate hematopoietic cells into osteoclasts, into tissues of the living 
embryo. Finally we studied the regeneration of the caudal fin of zebrafish 
embryos with a special emphasis on the effect of glucocorticoids on 
regeneration and wound healing. Glucocorticoids in this case mimic stress 
conditions in the embryos, thus helping understand the effect of early exposure 
to stress on wound healing and tissue Remodelling. 
In chapter 2 we studied the expression of a panel of genes that are associated 
with bone and tissue Remodelling, namely: mmp-9, cathepsin K, rank and 
TRAcP in zebrafish embryos and larvae. Differences in expression were seen 
between the genes, but there were two identifiable groups based on 
similarities in expression. The groups were cathepsin K and rank, on the one 
hand, and mmp-9 and TRAcP on the other.  
We found strong similarities in the expression of cathepsin K and rank genes in 
the larvae as well as in the adult scales. In larvae both these genes were 
associated with the skeletal structures. In the adult zebrafish scales the 
cathepsin K [168] and rank genes are both expressed in the marginal regions. 
However the scale-margin expression of cathepsin K, but not rank, was seen in 
multinucleated cells.  
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Unlike cathepsin K and rank, the mmp-9 and TRAcP expression was neither 
specifically associated with the pharyngeal arches nor the pectoral fin. The 
expression of rank and mmp-9 in 1 dpf embryos is interesting as it is found in 
the site of hematopoietic in the early embryonic stages of zebrafish 
development such as the ventral blood island and rostral blood island. Previous 
researchers have argued that TRAcP expression is a definitive marker for active 
osteoclasts [142]. TRAcP expression was observed in the skeletal structures 
such as Meckel’s cartilage in 5 dpf larvae, but not in larvae younger than this. 
However, it was strongly expressed in the scattered cells all over the embryos 
(2-5 dpf) more specifically in the caudal hematopoietic tissue. This TRAcP 
expression was similar to mmp-9 expression by in situ hybridization in embryos 
and early larvae. 
In cathepsin K GFP transgenic zebrafish embryos, it was found that after a 
continuous exposure to a combination of dexamethasone (DEX) and vitamin 
D3, there was a stronger and much clearer expression all over the pharyngeal 
skeleton in 5 dpf zebrafish embryos, compared to the controls exposed to only 
egg water. There was also expression in individual scattered cells near the tail 
region of 5d old embryos. This expression in scattered cells is similar to TRAcP 
and mmp-9 expression, and therefore suggests that the TRAcP and mmp-9 in 
addition to cathepsin K GFP protein are most probably expressed in the same 
population of cells which may also be osteoclasts. 
In adult scales the mmp-9, cathepsin K and TRAcP expression is similar except 
for additional expression in the radii of the scales in the case of mmp-9 
hybridization. One possibility is that mononucleated cells expressing mmp-9 in 
the radii of the scales are non-activated cells of the osteoclast lineage, whereas 
the multinucleated radial and marginal aggregates are mature osteoclasts. 
Nonetheless, the fact that marginal, multinucleated cells in the adult scale 
express mmp-9, cathepsin K and TRAcP is suggestive of an osteoclastic lineage 
as we found in other studies recently published for mmp-9 and TRAcP 
expression in adult zebrafish scales [42,168,169].  However here we for the first 
time presented expression of cathepsin K in the multinucleated cells and rank in 
the mononucleated cells.  
In chapter 3 we used a relatively new drug delivery system (DDS) with the aim 
of delivering the compounds related to osteoclastogenesis into zebrafish 
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embryos. We used mesoporous silica nanoparticles (MSNPs) to carry the 
cytokines MCSF and RANK-L into the living zebrafish embryos. This was to see 
whether we could activate existing immune cells into TRAcP expressing cells in 
early larvae, which are not otherwise known to have osteoclasts at that stage.  
 Before we preceded with osteoclast activation experiments we considered it 
important to first look at the possible toxicity of MSNPs in the zebrafish 
embryos, and also to assess the safe concentration of injected particles. 
Therefore, we tested the toxicity, and capacity for drug delivery, of MSNPs 
injected into the living zebrafish embryo. We found that there was no 
significant difference between the toxicity of MSNP injections, and of buffer-
only injections, as measured by several parameters (mortality, cell death, gross 
malformations). Injection of fluorescent MSNPs led to an influx of immune cells 
at the site of injection that persisted for 2-3 days. However, the same type of 
influx was also seen in control embryos, suggesting that it is not the MSNPs that 
are responsible for the immune response, but a reaction of the injection 
procedure itself. It has previously been shown that trauma to zebrafish 
embryos (e.g. a fin clip or mechanical wounding with an injection needle) 
causes an influx of macrophages and neutrophils to the wound site [180-183].  
MSNPs are very small in size with a very high surface area, which makes them 
very attractive systems to carry the drugs. We found no significant toxic effects 
of injected MSNPs in the living embryos. This means that at low concentrations, 
MSNPs are very good delivery systems in the whole organism.  
We observed very little overlap in expression with confocal imaging of lyz: 
DsRED2-labeled cells and MSNPs suggesting that very small amount of the 
particles are actively phagocytosed by neutrophils. With L-plastin immuno-
labelling, which stains leucocytes, more overlap with the fluorescent signal of 
the particles was observed, suggesting that part of the MSNPs may be 
phagocytosed by immune cells.  Other studies have shown that, in the presence 
of artificially provided essential cytokines like MCSF and RANK-L, immune cells 
are activated into TRAcP positive osteoclasts [196]. 
Further work is required to clarify the differentiation status of the TRAcP 
positive cells. Furthermore, the presence of osteoclast-like cells in zebrafish 
larvae could lead to a disease model for bone disorders and for the study of 
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effects, for example, of anti osteoporotic drugs. What is clear from our findings 
in chapter 3 is that MSNPs can be used for drug or compound delivery in the 
zebrafish embryo with no excess of gross toxic effects or immune responses 
attributable to the nanoparticles themselves. 
Out of the panel of markers studied in chapter 2 we further investigated the 
role of genes such as matrix metalloproteinases in chapter 4. These genes are 
known to be involved in matrix degradation and have been found to be 
expressed in mammalian osteoclasts. We studied both by in situ hybridisation 
and immunocytochemistry the presence of mononucleated and multinucleated 
mmp-9 positive cells on the episquamal side of adult zebrafish (regenerating) 
scales. Plasma membrane staining and TRAcP–MMP-9 double staining 
identified these cells as osteoclasts.  
We found an increase in expression of mmp genes, cell abundance, activity of 
MMPs and hydroxyproline levels during scale regeneration. Together, these 
results suggest that MMPs and osteoclasts play an important role in scale 
resorption and Remodelling. It was suggested by our in situ hybridisation study 
that both mono- and multinucleated cells express mmp-9 transcripts in 
zebrafish scales. Our finding of mono- and multinucleated osteoclasts, 
expressing both MMP-9 and TRAcP, provides further insight into the process of 
scale regeneration.   
Our results show that the increase in secreted MMP activity in the medium by 
means of gelatin zymography correlates with the up-regulation in gene 
expression during scale regeneration. A significant increase is observed in 
putative active forms of the two gelatinases. The amount of latent proMMP in 
the medium remains the same or decreases, indicating that more MMPs are 
activated.  
The inhibition of MMP activity by in vivo exposure to the MMP inhibitor 
GM6001, further underlines the parallels between zebrafish and mammalian 
MMPs. The release of hydroxyproline from regenerating scales confirms that 
the scale matrix is indeed degraded during regeneration as a result of 
Remodelling. Our data suggests that matrix proteolysis is an important function 
of matrix metalloproteinases during scale regeneration. 
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In chapter 5 we used a larval zebrafish caudal fin model of generation to 
investigate the lasting impact of glucocorticoid exposure in early developmental 
stage on the capacity to regenerate tissue at later time points in life.  We report 
for the first time that a history of glucocorticoid exposure is associated with 
lasting effects on tissue regenerative capacity in larval zebrafish. These findings 
are in agreement with previous studies reporting a link between early-life stress 
and impaired wound healing in human in adulthood.   
We found that susceptibility to DEX-induced delay in wound healing/tissue 
repair is seen not only shortly after injury (i.e. 2 days post caudal fin 
amputation) but also appear to be an effect that may endure much longer 
throughout the lifespan, since a similar phenomenon is also observed when 
injury occurs much later (11 days post caudal fin amputation). Taken together, 
these findings suggest that DEX exposure during early sensitive periods of 
development appears to cause permanent alterations in the cellular/molecular 
immune processes that underlie the early phases of wound healing.    
Increased cell death studied by acridine orange and TUNEL labelling suggested 
that there is significantly higher cell death in the regenerated tissue in the DEX 
treated larvae as compared to the controls. This increased cell death may be in 
the immune cells as well as other cells within the blastema tissue. As blastema 
has pluripotent stem cells in the phases studied here, so it is possible that this 
aberrant regeneration is a result of increased cell death in the pluripotent stem 
cells within the blastema. This apoptosis in blastema tissue can be an 
explanation of restricted tissue regeneration. Future studies are required to 
assess whether blocking (morpholino or pharmacological antagonism) would 
have prevented the effects observed here.  
Conclusions 
• Genes associated with osteoclasts are expressed in early zebrafish 
embryos (Chapter 2) 
• Cells expressing osteoclast markers could be induced by the injection 
into zebrafish embryos of nanoparticles loaded with cytokines (Chapter 
3) 
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• The same genes are expressed in embryonic, as well as adult contexts 
(Chapters 2 and 4) 
• These cells are involved in adult tissue Remodelling in scale 
regeneration in zebrafish (Chapter 4) 
• Mimicking stress in early life can have a deleterious or delaying effect 
on the Remodelling or regeneration of tissues in the zebrafish at later 
stages (Chapter 5) 
• The zebrafish could be a useful model for studying the processes 
involved in bone Remodelling and regeneration (General conclusion 
from this thesis)
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De levensverwachting van mensen in de Westerse wereld neemt toe en 
daarmee neemt ook het aantal botziektes zoals osteoporose toe. Door deze 
toename van botziektes is er onderzoeksgebied ontstaan die oplossingen zoekt 
om de levensomstandigheden van de patiënten te verbeteren. De studies zijn 
er meestal op gericht om de botresorptie te verminderen of om de botafzetting 
te verbeteren. Tijdens deze studies ligt de focus op twee celtypen namelijk de 
osteoclasten en de osteoblasten. Onder normale en gezonde omstandigheden 
is er een evenwicht in activiteit van beide celtypen. Ze zorgen beiden voor het 
behoud van de integriteit van het skelet. Het evenwicht van beide celtypen 
wordt gedurende het hele leven van een individu instant gehouden door 
regeneratie van het botweefsel. Wanneer het evenwicht verstoord wordt, kan 
er boterosie of een overmatige botafzetting plaatsvinden.  
Tijdens botontwikkeling en botregeneratie is er een balans tussen botafbraak 
en botaanmaak. Deze twee processen van botafbraak en botaanmaak worden 
uitgevoerd door de osteoclasten en de osteoblasten respectievelijk. Tevens 
staan deze processen onder invloed van verscheidene factoren zoals 
endocriene hormonen, veroudering en medicatie. Een verstoring in de balans 
leidt tot botziektes als osteoporosis en osteoarthritits. Al eeuwenlang zijn 
wetenschappers gefascineerd door het regeneratie vermogen van organismen. 
Juist in de laatste decennia heeft het vooral aandacht gekregen in de 
biomedische wereld. Vele vissoorten hebben de mogelijkheid om weefsels en 
structuren te regenereren zelfs als ze volwassen zijn. De zebravis (Danio rerio) is 
een beenvis waarvan bekend is dat regeneratie kan plaatsvinden in zowel de 
larven als in de volwassen vissen. Organen en weefsel van de zebravis die 
kunnen regenereren zijn onder andere het hart, notochord, lens, retina maar 
ook structuren als schubben en vinnen.  
Wij hebben gedurende deze studie celpopulaties bestudeerd die een rol spelen 
tijdens botontwikkeling en botregeneratie van de schubben van zebravis 
embryo’s en volwassen zebravissen. Met behulp van mesoporeuze silica 
nanodeeltjes konden cytokinen aan verscheidene weefsels van levende 




metalloproteinases in de osteoclasten bestudeerd tijdens de regeneratie en 
ontwikkeling van de schubben en vonden dat hun aantal/activiteit  was 
toegenomen tijdens regeneratie. We vonden ook dat er tijdens de ontwikkeling 
van de schubben multinucleaire osteoclasten aanwezig zijn. Dit in tegenstelling 
tot de aanwezigheid van mononucleaire cellen tijdens de regeneratie. Als 
laatste hebben we de effecten van glucocorticosteroiden op de regeneratie van 
de caudale vin  van zebravis embryo’s bestudeerd. Hiermee werden stress 
condities nagebootst in de embryo’s waardoor we het effect is van een vroege 
blootstelling aan stress op de wondgenezing en remodellering van weefsels 
konden bestuderen. 
We hebben laten zien dat genen die geassocieerd zijn met osteoclasten vroeg 
tot expressie komen tijden de ontwikkeling van zebravis embryo’s. Tevens 
vonden we dat dezelfde genen betrokken zijn bij de remodellering van de 
schubben tijdens het regeneratie proces van deze schubben. Deze genen 
komen dus tot expressie in zowel embryo’s als in volwassen zebravissen. De 
expressie van deze osteoclast markers kunnen worden geïnduceerd door 
injectie van nanodeeltjes geladen met cytokinen. Uit onze observaties kunnen 
we concluderen dat de zebravis een bruikbaar diermodel is om de processen 
die betrokken zijn bij botmodellering en botregeneratie te bestuderen. Ook de 
snelle groei en regeneratie maken dat de zebravis een goed modeldier kan zijn 
dit in tegenstelling tot de zoogdiermodellen waar dezelfde processen relatief 
veel langzamer zijn. Het nabootsen van stress gedurende de (vroege) 
ontwikkeling van de zebravis heeft een schadelijk en vertragend effect op de 
remodellering en regeneratie van weefsel op latere leeftijd. Echter, meer 
onderzoek is nodig om te valideren dat zebravis embryo’s als diermodel 
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